y_80?mBLʴtbڧ@vIl'6ے@y!H::::뛷|ot(=YA(}N$ĝLauY$3/( d$e?uu9fG7G< fa·t'N*7nS?X>e2E+?AW \}7]ħ/c5&nHgnPcbDn,uiv787MЛ{WaAWzh|1묛_5ۼ,7C;]Y~ਫ਼uz-hl㤛}= I4 -ڍn֙Im{b|xzՋyy ӻW!x+m?~HWj䨧Y?׺PMvl{_z39"sW7if mh"iߣݰu~ލga4it fio0m| a_ot˶Z؄U7gz/O#L7*<<U,Ӳ_i{;18n>N[qp{^8# <'LC;i @5^w5Cq3XӅQ,`'Oa޳MURUE ᦖzZT)zz3<@ʀ+uQkU1D'8_g:OWmFOUbpXtwN6 xND "i-ﻳjF>] _+v/Cd얃)~/o[F6NԃD_$sq 4T/{ćspz,HAk`[)Xgs|=kV=9b4-OuМ'Y *?'5'?}\M~^~>^^էWP`ӣoGm^4<^OѧOWw^}j|>|?|8=l4@鳛_߿:Fف"d_V#0 /F#ԋ!R`uMF׽tc.9^Lp+X&3n `d{^ݾ4y޼hܾnqCOX_TWfϧ>_gW/ێk¹ۿ{qfΐ8Kܻ]ptLvDd=%hL7 Z9إx ]xcRQ<~ U7j8"KUy Qhwz9u,O[f0eyNz>@1Q/q鍝Ah#/O[xo >́BGs h>aw7RUp|3r ):h^޾rWcuj0d7K^`г=q7w—Ij5vzz?DDyp;T*^|Po>×.n0Ӌdp}mw>\ ^n@&&$pdC9Jvv:JkJN^oZSi1lޟ緯F})-h5gˣ*< [nޟۣgCut,ޢl7@gHTq}q1r_l/Z5_*Ŵl[w[%$قilsQgaYz}U|ܟtEa݄-6SRGԿ>[2Vy3w8T;Ço㛳侉bwspc\|!wԆSu]l7"=?O[`.d>6>}ξ_[׃eOB t<\܁!>?L hݱ3CrL[#Oun8y@oO%@!mM%@;C˻![)-؍5 5h?mmo/a jӰ'H?S?bƛOdvZ "`{|ZSx߾ܢ! |B]S|{5$hy^ma+OGx ]Cp\cy)3(uAD]LZWU )m"= G3?̈is(]890-Ru'E)wj [^)g+DUN!D";Z}uVBVQ%O#XSHGd ,J+c&U<`J)d rBIA0:ZZE<%[1׾1)6~l7Ҥun1rZ^.-v e.3F1,HhzpTο}Ro!B!#@,wp)+[/wMGs]mփޠ"{ϿAvh]zsB6ltAlN_[GLJޛz1G${>oݲ&jESyM,GŁ7ݿQ{p`r¥zAUї7^LQ} M/Öu`E> d~hb`⟥M ѿ ߫աG(Wr>S͏N|Kwo~OW~G yܛ^kIz\Wgei" 0Φy8Pxe!ӿ >r/O%S"ʑkI}0$8U{ί~#y_7H464_o/lUa.Bxhr ,#.`s2"@ ;dpo"tDB̍e[;| og?rF?~p:/"POFq'do_!,Ӌo0f2Hh8dmƓ.b/?_.>&J/#׫!ݥ~+$ #;=dVDQ:wj!XsC|zU^{+}A;L4<&X rnGx ԽQ\m DB(Gp)2B'D` +`Eh2S5@ $ʗBڼ]f`ТcK;t{;@ůؙ<2HZ,1(X~߾ղataP=p_dJ "(waAW5UDJmDKH3 !S(tNnDeKԺts|.Tp޼kK] fzR26AZoTۥ+(P]g!Vh8,T&2H41-;䓫@uJ"(4Y"׋LEVI<+^H˳}}M}:OrQk.e_m1yȋQ0+Zֳ~#PQb_>Wfw;8Z \>L׌cߑvCOA0.MkNwvwp^din`cn3~{@A<<~3/>h";ez;q0dewKVbyЉt1Y4n5.Dۂw1yp^Xm&$~1%#Ge}{;1 >~lL~U bPvTv8q1nƗ1\|K?]]4/goo^qpl?~ǩ{{wݾ}5?xws_}qm0lWۋ yS~sKkS~1/A<9]n_-^Gj_fo/OͷzyvpJMj?&TS=oo_OE Q7bc^<]H?$?o_p\wvm\K5c.I־?2MFw6< }S η׬ݔ.G`?n5>* .M!pؙ^\tnmվm>/6Ҍ>AqTß~9Ylmkᓷo϶7ߖcWϷۇwmlH٧oڬםۑ_zpexN^Ƣqӻw4<~+ F|n>pZ=}y,q}:X^_oη{ip51@tWF|?_2:mޚ{\w||NF|x{7:@䫱_;}?|i>{u|u4ikAGpuy>FtPS_ﷇ?a}g>׼4foFPSeOS?u|x9yuzc}o_mL_<4 ; ozp|ܞl@X_HwyH!=<{QI?ڵ''3~}xvspl;ip׌tW6}k{K|{C\V? ?޾LhponϽ7}!xxp4m^nxr?u^_<_~y}go}l]~noO'߾w1^|~ټ1_߽tϫw7_/QHg?O#BWaL>}v.no?4߿ťw]|pxL_'G|t~239_wY7NRhEyp28h=k|wο؋{ʗ_}u0 OwשQWft^uCӧoo3ř?ߏmt9{Nwξ]: N/7adv+I&<:o\%>ޝݷƇo-A̩i:_| $|}i{_^z}]:TpԇC'so{؎ߙO=ܽ w߃_k\_pniK8͋ӷG/ywq޼zVut޿͎ճwҷ />4GOQ:7^}[BK^4ۻZ|~;R_;/'Io$>ۜ}|z ՗އ%uQ27kO +/>|3^iTJdzAc[w0H>W׃ Qw~0epuvxx~|4ۛw};pZ ˯óai%R)x}R%`E^5lh7?Ķ d/ :`A:W/'=LLg7NdL8)VGn]",얚wfhUvas]_}.y%'}UN5> e^Us0b yPbJ-ׯo/ ڞ}{,ooorT1%y`\hJ`4jx'e5ɯ^$;x&t Xڶp/q8bd3]4yK壜3S]4Dd9]9̜V`8L "wR< .7gJMl}rl?޶\KXowAN.pK&< *o9y;M/,\`ULZ*UB"ޔg}YH\el2G Ɉ53 [7+Px)ࣰ>Ws׋,3Xl&\:ſn{pq&'܈_Q]}b{ >EzZi+??TM*eNSlswAޱ+طw& Lr8P\3ߊȧt2KwQ|y7 {z?~ޛw%g::h@gw)t^=&[~_Ƥ0N~Gһڥ͆H*œ I)tWf{:$X%2+,{A7p{`+/jVm0I&AP8_u?QWIK"KX_zphp{!iSi/66W747}/qCչss$P뵤UsFwUt|RoNN$vojޏDBQGAX1:MMJV1gԠzV, =W?M;j83cT}g5{{%Ff zۉeo٪ zaw(<ɢיOMEm9eò&ivo1)̻ZG2_[5_QKOf0N"Mh(VW^搪 I BwPg'Un4$iII{ 4h5qyN& S/f+Xi#|;eޘ1T{Z gѴ;ȏ^XshG܍aw &C괾{EF]?J#;ƺS68G;n.]QHmdkgY:|o"_^4f*jz4 peo~KoR߿;.|WZ hIҫׯ5 ޝg=vӀQ͝W4qfic {rka*tR-Iu,l-K9evMY{/PuM@yQhT[3y1V}c`iC/ci0H;Ad8zV6 mV@\g#+|R,D,J=+P{o9Dy0)`h J>N ͣ`IvXK&'(e4U۶L4,\?뙾uFZ-,cXM%Ղͼ ˠN{ןf0wC;3S?\ e "ˤ4D>_.@;c8M](H<݄e:eۃ!Ī/8nҚK~sXF(Z~_,kckM«OWwATSƉ $^ڦ$'1n*N6["&ݬOBG.9-:%r횛Buu1ݕ:Жrϭ7 kXLfV6މڮ ^w͞;bX`bހ4 F?eQOrjM95֒3z6]rUXYE2cyK+{̍h؞3>@ף~>,MIV2X9K&v*!{ zͳd[߬gFb#+ e mljL`]@e$؍ߧ_;?|BIqʪ`5w |ɔXW1Ĭz5˫ !v-,dkXc%@q6]̽\o8 7@ '`k/;*u R%/[m$n&ĿC~ݤFWu84PFuT Sʄw?өO2̼6$?='?S^żIW` COP*/IA(G\!Zx(hj!;`M gekaMtd [I Uȟ`q~Ӌ?iTu DE\$r`rkѺTSж\mhDY`)+!¾;/ٺۛm#7lM{U+pp0v68mI2M]#P0ó"`^a&]=pRhj¿KEG;fr ѭ6'h?^S5Wvo`,azBiZzab>!Zw,";ail>u 1T(V "QCPyw!,xاγUiP`7^#nU`vaydK1W!g3""Gs3%|D!&° {dt"R$2?Hg"UhKWQȒ  +kUD)"ĬT P rUWIh=Au o0f"w ȍ0XSZE+*8رrVc9b6UX0X.܍U1t+'Q=0yBCm)R¹Y !Qiy˅sϝ A)sJB0n;0RQTN 0nFeYoleSآ(2oꝺ*jUeO(vVa ,"5ta8^_ \pRY4&z/ YF+d \ l~UA`o DZu]-Hߵrjv& 񴓢ЁQH,bo CD{"*C⧜NaW)N;[+jUK]32W);JMMAk,%W( IS~\!}h6Wn.axpXyܥ*2stt0X`f ayq3Kw*:cGN德JtyQp A8lt ke*X x;3^Nݣ؍c+RPMxm j♱4%-\F-nNԱrjO.*&ln2!PnߝFÁtfgޠ~='zDAF;4ǹTNMM"HEN '.Z'i `x&*=n6e8ȁMR ,-8l=u?pׅn؂4[+c9D&Ghj:6qF])/a쫇WXT K]8]̜`k 0Ǜ3ò63vp& QVeZ0 p"ڵM,R.tu.6y섮д R] 7ҹogx~vj4r5懗AܙRviu\aQ%Nk( Lƻ5_[ơ=G'T1yB.?'AuI3gcm|j˩NL%#U4*5)oSZNuJ+\/p GOVc, }z oI\dMGj:K@-.bhNt#m:kl5Ks2[.N/ljfLQ4ռK.4 r"nՑyV(Q3b.Z ׁ\(3Xӧf!zBQg)RL67.2v7"1ji`uzq{8~x#-xf2j㷲?#\1?dyj ,7׃F<0܌l^#, -@43E 0] }UxMm&Rs؈'?Xۼ+Xm{p r7wxE^-̷jw=enbtMМC4ᖉn(jt:|͉<{z!jfy'ꆃ -uo{'(S~e+* -Yvys{(fkc4f/eg 3ڵ*h-%?/;7\(HOSgN WPzI("n6 tRUߵh0;ݾmcS;?.UPL) 1uu'TFUj!5^onu9ݮK9ϖxE-Sč „{ M-rk D,7==  uQB_ϝBD` Sx^ט}|މv; (pWK<\X<$,e]jZVo6&`ywd^yd7bz-MZT#JQʁUvO}P`GYgMz.P-㞙jY긾*4'ذ;0Fnͷ_84QGz6F7P&]=oƮh4̣}yBU+WfU#,{Coڛ~W-o ]g⡐KƖFGsun0L ޮt*7'u%|+!oagjDR!ȳS3*iFU +o[qATgHEM+N (Cr*](Nf51O OSY)F{?  y^$^{Ya6_FH_ n}K3 +Q,U,;C–JKo%yL$|p}#4}0LVX )&YGeGIch2D \8" ZҊ ,5@%)7W-{E>h n`ě&ҲzhtVXlCjݙ5 M69muvģ/¼%0C*KocOF^VCOez"D$1?;`6v6ęfޝXzS7ڵ\׍돬Qv”8Rt&\DH`H ?ͩ8]A:sG &QK}O6TRrKµbaLh/$U=IRZU ΢TI"vh%`R&wʑ BjGbGk]aIIJJuIB47ȼ*|sy$Up^dN UE&賅K{Gb4‘w5`- -: yB+Z`Pfol3O MGfI!6#dqzWGx?t]uxn92ף!!$3IJ1? ㈓|FHYCQO&Ap(c?fؐ h?&!%2JFE47a b曟iW^CS -~釹 s; T&9wn6Mo&)ȴ67gz\NԵBdFl`>ll :vr #u *$}xqGd#uA8dA-bH+î,:4BOGN!ORh7u? >}N04v0:.1t:#G/D$6gSoF )1_9nԡw0mA!+8ƦaUu.[h8+&v\NA|urK2J+K)zd4[2oTtCa/(@x~g/@mnHV C7&k4qM1 ۝.{6v`؟ᴀ{Ù6Qr T!3³ʵ$`O #R3*OPe1p͖B[- :|-wHbiR$=N@̓LH[.\^Qمۭ^p{,FVWM!%TgJ׻Yv|q|TUz!z `Ub8N@D!a bGQ&A=bHiP&]GX=hpnFԫ[QT ᗩz񕮥fj'~*,f>_39JEK^U@A^6߳'*&n'AaN{D[ bGei,ҔUog_ hH >N++Ƃ_㪫Jeܙ)r433dЍO*)iAOIA2QNqWf M_Iݑ@}Hd) \6HLOiIxi L7$G:`imVpƃsƋ-q*4=A Tl24~< +8lTߪ=$prz9'au4mF:sC6Ul3V}H${khVk(CMNܬys4(+jK  QBSs; ķroѠ7Ri7+jnԩ(hNo@8тRB74{$RP]HYyO`l@vlHFǘ g`,%JsR&, +{%Tf jDPRϥ%DvMT,o Ng@A< -qP?dfd.!囝+T'Tfp˥6|W\Ffro)ӆSB97*;fiBsr-p], RBRPȠUoP!8m" 0U,] oί7C C)rN3v5HuJS׻AE>xJuE) +=Y!CXJƹBd]@ &i VQQ 0KM3J<3 )[OD/ J?7W8e􈊆xQE̍+,=:u] :˩Ab-(|ebaGeё%GZ7aDpϒ{ ʘM.D5D27LoLF"<ԋ̤Y8s־b$?ߦ ](UFn$#W'42|e h4P"wŃOUT~a>*1ExxaCk39jUedETSj8/$"o=5AU+V|RJL-F _dPz^\--hn$|" L%'Ъz@R&W{/_Hغ wf<ޢ`„Ap̓w{۫ bio]694§/XBVEpId0:VsgG|S6$t(;U GwI tNTKoh,A1i|̵[aS/-ӄG)4bWD$͑B'n=kË9 /!܉[y/ Z.-W1&:b@/rqZ|\pGȚ鞀lܡp>| L\M-9K.-Ex7]W˱v070؛(dmjܕVFG1ej6Gulo( {TIb^ sMSF 59\st[+1{)َ'[el׀3tz:Bea!$ #d t|}*Bǀ%9"{{57ڸQtRY3tۻ; " v9WJXHGs[p~X2nBv=뵸IT?'DZ+Key,T(L۶c O [pP} U,D*b첥e# Q9bu"1TJxYĈQYD-hbq;1Yԋ\fr,RzsIOI/#"Z4t,u5b:Kg+1ʉsg64cbREAyRb@ϮM- kiGdy;(2-.3 )MVmɵybD GfKxS5|pbeƏ$¸q.4 |a*_/Khw_]WLNRRPQZ3-kI]>%?잔[T{~DY]JK%l--Ko-;ipAGNdz;CYدjÒ'nط'"kSYd#] S7wn /]?nЗH ^i,_ѐh[_ZEFNtG]0RԡUYFacnArO Q,,a\s5Ur7Q^2tY̜M=U:*( < %z:Q %N kcs=y{a3*'6A{!,E4yo6`މa {{cWo%̝XN5Kuv'EfYs(p:Qެm1M*._vebztbIط˕ ( i>#_?]aTyQDHd?p0G3\M#f4a8s(]d`Zn+v3E2q@]))t`"w "aߥz +N^D/DL6J)J۳OId8sƙ5hp:feRuc$Yg% B,7Iu.' m`_hcpS;icEHÃS.:vXGr>ˌMGF0k``]c5`򝾞x6 kܕ={DGXkf訴Vvę &,*vmi8]q!{]u :Y;Wþ3A AXGob&go{{{TJ0qTpZ5FM`ԈȈwcϭ(`ZƅmIAMCwW|3h݄wJm.{T@XlU S&)p6iա" |(4wG)?+cXacR/Zu 81C]G.q͏aEč_~ݶb Z-?Ł871%%߿) r@𕃡͐jֆ`EzWǯ6[diG>^PHTF>LUYU.ɢkd5!qr^xiV6i38X4x-R;7"`Ul#CV}Miҧ1 ;raOBORL2r4(MñAK!uJJ|1AleeQ"vh*yLCp(B9Fl\GfI+ Im1_gY;4(/dpJWf# k`U/u/)?YU ojCugX2HX56' _(4ݡ[bl wsZ/8ƴ;)GN䀟mlL5ʅYבؠ,AD'0qzQ(SYZ0Q_Zn_?代f±٢X^jhAYk D cKeCs>]*j}ǖ᯽X$<)ГułzP{?wk6 /øRO[7UY8J]9KK6O_њՂzqt., P±k y>+g؄ڸq ĤzV;DZ@ġgj&Nu-8`|zy^dQ&!?/A89諁cV/>Pтm:lÂehݏ|uRg{{Ro˙g_y$q]!zQmPR FmaMV+,"(9F\^xܐ w>y+efҟ#gj(XBuU-=R5<TsS*:5#JV5np6Bwkz)Y V&< Е SnSN-}扻E+ Z⮟mi^-l0$_. lʸLBKI,"8'C`r{!Ig9ӔQ,憶I,{M`rTh86h}7>EM]Y[ǚ8٨%!NN!cU9"#-۲s3n8@nz9e1У(Yo6u s-{0 ^rTa@9,֪s6fi"6&_a'tHtPt2!_y92 ӑ[B-FUhԴ‰1U s0ND"W A, ȁiSwi֙\*\q".G#Tf۵Nƙgq (M,̔rj/ U7[0`ot</3qF|yXѨd&ӡ0מ2޹T2FMǶz:-Pt 6`1簕/NYB@± s`aOe^M(|2{(3<<bܠyF}OPNFJktg[C7sKT&쮞x= W nn-oCe@+]!;¡7p&ahMIFT9єLeMx CI(m { \ˣ4SdX8NY&GxXÞcIh5vd`4Tz~Zp˱; 3l`^q+2˪Tܗ+,<p1P3OĿDN$"j`x~'1g3&ݝq r! ׭gRwb1k3B4!h>9I7eg>toƽ&WG-NJ\係^&Y"98]A.砂P*c`jd&3FIf *h5l^ .>y&Ѥj~ 32CpNFCM@f3] H s5*Sa"TAZyOy}( eе8:5reh`o-j%~9yǗX`{*K Kw,*Kk@e<溨h|Y@XjJ?-}G$T%FύDŽ Y!QN??׀'ځ^n09w'*2r-'f&(ݓ#S۵^2֧,]ΕAiGq8wDqo$ӹ!GQqhdFm[9yO Tbiגq#6\9)l<v,sЃSlv*jVIRJa^b ZEz0 _AIKMnIݺQ/HrU֏Dz(n4{,&[M\WF6w5 u +G5n kxrDQ*ڦe\)irB$ LXz'Bs%!5Kt[`폰 kIxQwl\j`uW(>ODVb_K̵{tWܠ%iԱ껳i\3OJ,}no&:`eF(ȟ PwQn3vIJz BG:vf'#s QJ3O߱Lj eF!xRxU+|afTЧrXc pyk"VݠkCAQ*S@)LUȃz; v՛vy͇xLMGr 8h'WmcQr]Yv?ֲ(zOkz;Fv|yaY;~4>'ГȖ~2!"$ ((2g ](nNSc.fJ 4V:I7w4=}DzmϷSqX՛#@#{BOhm䁊a &Pmh@CGv-:NuZTgix”<4OX]M U.80t!Vn&]5NL/xz*jqx-~m"$Ez,/_I'nDJ8ؓxBͩىNtXu-=?sr8si.};zAZ4uQα3'*[z<⺯y%Nj#JqqԵBTIWu2 >}r@n^;A|w%* =G4j|0ŝCQaZ%k]zļ79Myt_2XfI-=6سYu/ce3r1v^XÅ{JT<499tp]"Y 2v?_*t`zm(e^7OK<\#OEt@{eD8% !A3싍X]$s=&&#x؆Zr/%,ԋvcs#ĹJ2x%@kRQHA*CDML-;q<ňN!n%񷮍hVOuM06TLHo1<`zu L&0cŪTyNy_!W(qv;o䶀:#ui2mv;ei`O|ltCc\i"#$B\ݵgXh$J⮉3ro! cNBJk¿Kl2Śiobdu|ӒjT]}_ lZ.*4A !<ңp^?ќMB:b:Et(E~-<<2`>G÷իibΝVM%Ǡ1Ǜ(p:׼I/n#4ogImSNMJIff50ed}lakDC$ @~T6XtgJ^-* ődwF8ßqH(F.~wY#^[lG:Bh9F SVMc>6zQxK -n:95&w"0qqqL_*Ld}yj0＊ Qî]iRg2\nƭ͉p]wM5Q䆴c"Sp緺ZHY~LU˪ǔ$\xf]qbHtt ;&gyH14 ulW?i#2Ƥ_OBE"TlL&KT:\Ѭrqצ$?5[wZ%w7YZ$˹\ӮI H&]=a!q}UK*'wu0AOd.%F3)U=<.4AJNJ_;VI7pvJ3rYEky35AD 6 <{w6$200]˲0z_f\@Z+K7Q;Ù5B~xeidn|l6F2Rщ-d9j'fg3Y,'[~^nе'-^NnǁNbyJgzPZm7FHK@k@$Dʥ]k4yU"hhd5AXV)sn x9FQyXJJ\|L*ZVz~XMӊR:$%sy v1[1+D4wt(KʏЧ`pG(~@~w??6h઱frrk*-op~R %oG܃6g'>2B,s&hZž_)twXi8]fmYo[Sݣ`4JWJfY9ݤ~| f%ݭi˅ꆻ͡Լ|-(k^mre0]*OgGcS~9@zdZԛ3}Z.'\ké2}ul"ׇiFk+]KbNF4OqB,{'K+f X*daF[HY*<`s*` B]^؋ u}R>6cO< 0wzqSc s|bΖ3IôcXø'zH{ajESG5 QחL,7`L;c_a6aHp0{ .c`uZ{@OI'³Rǡ `-Civkyt7L] c`hrr=R{u4Jb_ڴמm؊kFoz״ ]@K*fux$@S+0`~1~Βֽ!2QYV* [hO"Z1Vy`WCMޕyUrpŁuƴ2/y "Zb%;ԝLQH_/K:A樌^fc]:j"L>O|jQZ.m+7Ы `$eUz:įO&E3:Q*MhT`۶'d<憙lQ]k9qc1t*Q(Ў]/\bꉦ3VsZ|m1Hm8_8.Y>XMy .կY٦nUDHXϡNs &>,-K-IvE噧qJ:嵸~qdWԒ`9bb'YLdUƊ\D7ȹ*HgƎml|񳦊vڎx S ܁M PڽJ<Ͼ )4]"G_¾Ld&jvNiq{̝Dka6BD,<%dCV_E FJ8 hH<=,1 Ex^g"эj=68R#4 涥-~INGpdm:,h?ė#C@n$)8X`l[-ADBэBG(@M׊pzgV5֥U"ͳvֽu)Jnj8*M<$8 3 -7<.Дu3JrӐ_X{z& ťN0,is uQXvDP*0ddq #?ڧĞPRCAeN v TV_dwĎ TG<5`%=5=n(zȯx];h xrʺf8UX׳pV ׎ל:@p`tRS?a¶籗mxeUFR/wpG1 ]m G4dԵKmn{2KN$̵ZdZjpP m"ljnG)WYƹDmtℹ4F+0_WF}~pc4WGÙFEjԡi) N~(wґ\L[$02 ЍW- 28&9.ڒZe[$+v*|ܪc-p,?td,f>gQ6&.j82I~Pr~m|OJ+N5D%c&n{T &LB@9^U~+2?T(/!C{EBa>WA#m(j2 ~7ML<&/- ֦슠/=knFWxRMN@t.sfӴӏ,}d$(` 2sgEI}1 c.1qDF}6Hd\qO#(HQ:,g2H<P^7v፪]LIAԤʣ`[U2R=b[˜|}(u}Oi7qRF#={khz=`!*RR,N٢*)t+lr,cB;AodFyj]}}3Mh> ֠tz E6 OV'T{BVUĐ% pIj &:0h׆QIiO 5N3eZRbAC}uWS " u:& WiwqP# ŝRiL˄2OJLFVv%Ϊ'&eE*[6_gYl >aIaP8V 8z-^̂ꅒRܐNaR:m\du%G魆$fr7 &C4E YM4]::Σ6W,ghZFh"C ^Ze9 v_ݔZU;ł?@i7En^x?alJ>JF>ƌLZ.Qt<7uSZt1r=XvS6=m`dv l|ŇGȇ/_'!2nMmRps:w"x:(G;GD7 -8iGjpBciqrC/S # z+Y]=9aV<ދ_n8u @: S ngVw y#-vegAlTxJlc)O|\D #g;CuSj>N`fvG0s t² Xen sXB9Q;zYdl;MהSf9RpL'\M=qJCje]s;bXˈg-n=y.J+:;j gi-˅#@%Y=:MbP_O ͢+:-(]ӂZ5{:̅̆ *l*RU!Ȕm /s͗Yn*g[6r-2%Zx!-x/۲#2m ʈ2q2~'Cse)I% 5Se{1Fé:Ҝu'L`ue9gl=ȆSFIC皑* mX)TW`hSl>/'`Ji7k%}ݑd{^f.H9*. q?YP >64,\?뙾uFZ)JRꎣ46EXGs-2_VIE ʲ8aqHd4s?\;!V/J{J4OÙެ<;5N3f$ˁ33h aj \-@Jzǁ% zkI˵) ͌\lHE36,팘"N!,WlxbݍxZːBv 5E8D6 c5:ݾtWE]iipm1SwTru™Ne ' A>\&{J[ۥJ} .Zۯ#C*<hUSs[(2}(SG?FIIX"i&Л jqwuVra[dX0O sUp$gv )s6QP"4=l?"zkkt):)(8.컛uu^ s@3cq~ <_V وf(@"AwH/h#.!0*UNP7a8=G+,Y-,:bnFzPXE 'fS 6+d%$8j+lj%'xOMU-mijHNV(eϋ?ps16Aޜ8"kˎi~iO$^;-tuUXjE8P`c4K#QA)Δ$UWf!Sf,Y-P%tda#M@8 soWGM``.=b)s s0T&^ \#+W@?1=gfxSukOD`!CB=%1ͻVq -=qQ>\ U& S9`\t@Vr~*4.tFXF~ţDΘhX_Vv?ƬXս+.1  =rǬm\ fh4U; BzلI"M\U;ܣ<V" .ηL3JNv͖ G. ܔd_Ytb}F+;2kz%_di0pZ~0Rx #$B6p"#1Ǫ$VEXq 0q*.&rN )?~~b4"hOWMG̹P:|B*rHFHuqݛr&jF" -%{> U$o nԍ%JY Gr2Շ͗dR5 }lm}&iL7X4K`rC>'R ,b6_j,84]Sf3Ls'D!4ylGxgf0{x5 "=UVoI1($*EgïQu&%<L[9:TI&ѼJќ-G+xA >-=TߥEq 𪇘"*!n6u\ NFqHBL0(jjM)VS tuL YzSuTF|! x4kp;fA@ }{Z6Z.u0LlO 4}ب'īN矋~t^Dϟwy{?:xDe?p+dmj2@-ٸW" Q:$ԟL؆t eNF)8)@Fn ]ɂwi/<x 4Nt3Ss"2`{Lzh#k:5 _k_qv1%w1EtIgdOfފc $]^^xnz g{5`L9 JgA`&|bz~S}e~6`^^B4}pCt7 1/DRl iVgߕ3@\ |#oP+"o)\|9{$^@jY/ج*э8N[wQyd;0)`S${`WtOq➒7oĨ52JYۦ޵XqT6. UAΤ638f1~YFnSQ;yL*Vqtޙ )v`ðT_~_yQaC4Ѕ7<)+: &eF"z.ēߺZj7C aP/KgLQ<D/@kP!1މo꫙@-1*0?׍Qi `}ZE"!H)%j Ze:86{sҋA-RRԟ> dkǺ5# cQ/XSJ{lZlÒgH(t;V}Vo0%>ǵHU L VRȏ"멍)j96\U;au6HxFdHVD o7 ,;s(w|D ]wʬU:q܅|=?8]d#Ow33.ce[5bh%a`ҤM$CCkAE2S̓b?ebYѢ%haOTg)[5 ɣnjV&NzN2'e|d-QY 7Z?}ᰄu4]#u)pS7 '"@I,9}t /:YX4^P j.`ʳ®kfr%BM ,*F=,&;0K4ثB yW;ّiǽ~Ux,8` f"SEt֬:im˓C]Z&?U ]ȞVBJ"cՓoV*$xD/G tK$6ȍ:fa8pB{o%:2ښ/,B*<=^O6l˧C+bivɉusZ%;Ҫ9\ҚxG~뉼7EW.r4MgvjCRe^_i3ZE'Gꀿ9LF uH:

М) =ڳ< =zTKb/E~dMy:~s\hyp6U\Н(EܰQ<#,fa2/T*)ȎXfnQ N})꼇*W74H~p0>3l_=Pd^-~v"1GLf”f;},BAG{2 ?/Q .zIAT }* C%:KNYhF.zFVګ3{~^ıF/kpfׅcԥ{FSH%0ns f^̖SdkN;ʻ%TrZ`2 R@VɼnbBC75_e`244ϦӺZ<LպD PyFQOV}i#7K 3_,el3AFn$>E $W#ݗH"Rx,ӒSx.+'ss;lqxxN.' ij m/4dT|Xnʳ k5mO)Gy[m<;cTBPt={EidҫMҢ2;")ivh@#=<v9'5͵˕҉LL(߃ a$t%s/ŚAO_*ͣ3Feu`E,K!|ӏ/bs(e_4 Ol%OlH{DUzXgƦJm}NtA odŦ!~5o[JxZowWy@΄.}?k͇m֟ &,eƁڃ4@yl@[ƲO>Rv uŝ.Mnn9Ԉ$> [Q+†O6xM,6uN4ABG(bSgJƤN#,ϓ>!a9d,'H0=}ZUqI߹EGBb+t'k@\%ہ)[ 4yG r}߀GLs7 y#EomitdQDSw /zyߕ]Gmke۩},S:䃄Jx,9Gj?[[Ti%8-Ub4$ B%$8BH7Vot:&>#|gM2f1 ہ*Do_;[1N}}=kvv <?UsُYcпh_bªY# =Hg JQcÝ0Fo> >*H~mTHDo4^~{??U豋[A>Nפk/Q[dFqqA T'F /S磖$.b!dSK}:hw!uw*XUst\֜>;l8Ѷ:bPW+Akl<0.`9"a:efӝř7$oh< ,u *"6$ֳ+3QGG7_}|H1tҍtJ(֨=O{`CN-Q̆wCO5 [Tpõ7^VeӐ!\5˻1qhLAІ>nK $Jn}F٧t0etY]~AU 1Sv9PK9 'ƙ'sYorZ-j`lQ~0T[8sͦ,QBvQUChRњ4XAl<}i ƪ@3r(b0f9xmz[lT6#gHfMf~:Z(pJs|Oم^bݞ }/᧟}#᧟#H}ϼ bK }=A\" @-mʀqwۺNqZ.tڸ (WX0I3Qg.~u~6Ab FCP1~yV؈Bby,- H;S/Z3m?J\יH_#߼w 6xt|yzX|3ᘝi[+XC0p~jGYꈒ^zϽ,_谻h?[R_v(YciSoծ5ʝIr{  Tx-̀oP-F^dK^ed0c0f|!|(/{r={2g_6IW d%E?pGm:r6" bxyzHf&LVnز[OHehxM"MUdP> 5TJ˭/M5Ǽ8 Iuk봴}gg{^=w:2f8tS[~mfüI-xN2A38ׁi6(J{I֣Mc- !T:ȭNH=Ic@D 1^!pp^[f^60БQuQDufS2P ? +[Zڹ^zfJGqA(tKߙYƫ+_:ZZ )t\t 0>)g_ϑ)/?[& Xd"5YWC:Q؜NZnzG,"ʥѫKSf2%zE:륷!P(M˷0 MyA1!EzB0=2%ozW2.kz(% 9pt&Ų1,"M͓os"˯T=sӖFÕ7y,xZ ~I\XeJz;H-Gm3MSMj4uXrX~]< Ұ*F>$(!L Xesa!gQ [¸1l'a.[ك[M.xAd8w& y,HY˨ud_f$NЫc a9e_$+P.LW c%愘 u}c㸜G 8#}h1FMpԸXU-sWFV:.WVHGo"cA)NU<}R)6PC*/Q9}w<:wk{*O:?t"r6|iNWI$ꁡ ` t"2n4=L<$q#pyMϖSnvTRdtu봩gw/}k[]'hQsO"}h pn y䘶VX_(жlGŖٖz kX `^'#Wsmqnz(06~6IOi*A:aE=I\6jD,;9pr]ؙL' wEjI"jQ-ӟi 5>h4M1E3pc1diBS\lj_/ی8  pqt~A)f@h ǁ\Fz\BVc ,)ɩS>\U[@ -X˫ݥڜՁyghDG8 >Yċ'zEI ʹdBbH?nVJj_t [`=7S\DF[S:LQ ےCvK gѨlEefyaKI B,zte|Hd'M-ugզd\6sv0֏jDt>y:}SYul}΅-tYr"40SW塽PUw n׮k}|ނpK\ | 6r .je4($[sګ_P)m5lӉYYR0ŠB[8"I<CQJCJ耵ha%ͺKhgtlF=ØgTa &\)ܐӍ'X?l].κ\ػMpL$;DcpN]1I9TGG~k>΢uygS1ܝgGļ*,?i7; b,S낊T^FS,yg8e}.eZWv.7Dڑv)5ܽߴ&AAOBaEce0tIX$SЖt]ʧX :hÉ# ƫͩt4z1^uZ_5W&a,lۘD-+k/Fkgy*izmqS |$ao3g+mm"y`S}8b tE֨1ɲ8;u| x^ZfK*# &HUGwE?_$x5'zbc1C{nBݭ H? lP,J ,c_ƻPu[TM,xcK?  C S,eܪ]nuIJ6޴AϧxaɸmdE%}x)& 'EPXZ`ei2Kq1'No )%rQ+YzӼ5z_|}9e"I#:5ey`1>[B~֘&CSB#]MfZO韟gY`ƻ4[g}b%~XV!Kkjb<ՙVJeB+yp{d)z]w]xh&W{w:q&=L'CU?%j-LOŹhc!i6׍x ׈PglJ;~$C^A6ȼ4ÚŅQNNU% ô#{^\+6z 6@;BY)!vd˦zdm/̱cSvdGXJ4}M֥ =He H ad% Ơz7 z-"ٜ߭t}Y8^O9ANb6Þ6P׾Z #+]|:}uA(܇Եor,nG@掭.AR9U!s[AwI#$5C-A:}}l3bP7@Ab9sWL6\ZT-el/v˃u:aߝ&dMnN}Y1߬iNq $Cw 7( A]а߱ZAv4d^% ⟳|KVј&iqf@0AL:G(莏&s0UeПogLsj+byvuo%~PWzmϝrʐT%YSpJ”I/mM}ɦ͡ΌtuZ8 f06g]9*D݇]d1_43>deo 2f '$jCq^e;Jcc "Jǎ5\Soes4,ګ۸FD}p[=}NO0(IRK洚|@m,]u}=V+ f*W *}5w ,ý#'Ǵ. d Q6E:KzJs%Մƥvg_%ȼJ&G8.Fq:ɧ# tf $d& 7n<'u*+J/^X]"605| 4P&8,p,gL&\i~0ow7>?}&wd:<.&"6/fyah{'Eli6tv,`g(CD$Imi ²ۭЙI菜0|p챈Օ_σE~aj)s͜&YVVpY:;:ń &!67hp~7m]%x"%J8~Q j;ͩfȬF/U(gwfuX0?ңO۸D_Fj=(Fx֬$#}-|".ԠuYT4V683~}ȉ^@Wbה99Ujꔻ{^8/c?&:6Y,['aDZK2=1Fk\S: ,ISA UNDo ރXx%I:!.0V'U|Mn&5jos.*Bjiɋ!I -nrɊd E$ƘY H?58/$a(*i`Ӧpvu r>Xe<^tm?|o:PMIt`ZgQzSiM.)U[z#I$'@5(R?8ɓݽ N(h|8l$Pl9(#mݔ>-(+mZ ˀR#DƘgASM=br4MlxEqzw 6pu[u~VV-(n"^6׍_m[<4x+U νk?DMxE1Tze}mw0wP>YAb KGisZ^vU"ݾhy.!QaKJ`8# '&bq\|:qGc0HO]: 7zZ0of2X_{]52%2/'V1Fxzɓ-)ZЍu3"c#3s'-泴,;= Vpz6-Jo ]'^gho<*Z Aq6*vOO2i6>A*LMZsΐVQhL:=]#[dy=Gʧ٦#BWW[[ yAtV1f$Ѯ ݢ8D*kl rߺ/mzMa 7msڝi5.\ԝFHrGRp_}@}T&J?/w+z8̼=3W|U̜ypl"W5²"<dmzJx0 -|-E) pؾIbRKfF0\$Jg+ Gw`“4X ;/ ƧݞY> ƚ(GJd`] 9:fq߰ⲱ}W|:-j R5Bk4*smsU(BN"pMm@ȝEҪ&̵f0VgKuE<ݬ]qe'M7|\ҹ9OΡ/gq=]^E\,9Rr_շo, ۖӑwj]n.[zO=ۢuZPѰHUVՂPu-e:9oAQ1ce2E+?AW \}7]ħ/c5&nHgnPcbDn,uiv787MЛ{WaAWzh|1묛_5ۼ,7C;]Y~ਫ਼uz-hl㤛}= I4 -ڍn֙Im{b|xzՋyy ӻW!x+m?~HWj䨧Y?׺PMvl{_z39"sW7if mh"iߣݰu~ލga4it fio0m| a_ot˶Z؄U7gz/O#L7*<<U,Ӳ_i{;18n>N[qp{^8# <'LC;i @5^w5Cq3XӅQ,`'Oa޳MURUE ᦖzZT)zz3<@ʀ+uQkU1D'8_g:OWmFOUbpXtwN6 xND "i-ﻳjF>] _+v/Cd얃)~/o[F6NԃD_$sq 4T/{ćspz,HAk`[)Xgs|=kV=9b4-OuМ'Y *?'5'?}\M~^~>^^էWP`ӣoGm^4<^OѧOWw^}j|>|?|8=l4@鳛_߿:Fف"d_V#0 /F#ԋ!R`uMF׽tc.9^Lp+X&3n `d{^ݾ4y޼hܾnqCOX_TWfϧ>_gW/ێk¹ۿ{qfΐ8Kܻ]ptLvDd=%hL7 Z9إx ]xcRQ<~ U7j8"KUy Qhwz9u,O[f0eyNz>@1Q/q鍝Ah#/O[xo >́BGs h>aw7RUp|3r ):h^޾rWcuj0d7K^`г=q7w—Ij5vzz?DDyp;T*^|Po>×.n0Ӌdp}mw>\ ^n@&&$pdC9Jvv:JkJN^oZSi1lޟ緯F})-h5gˣ*< [nޟۣgCut,ޢl7@gHTq}q1r_l/Z5_*Ŵl[w[%$قilsQgaYz}U|ܟtEa݄-6SRGԿ>[2Vy3w8T;Ço㛳侉bwspc\|!wԆSu]l7"=?O[`.d>6>}ξ_[׃eOB t<\܁!>?L hݱ3CrL[#Oun8y@oO%@!mM%@;C˻![)-؍5 5h?mmo/a jӰ'H?S?bƛOdvZ "`{|ZSx߾ܢ! |B]S|{5$hy^ma+OGx ]Cp\cy)3(uAD]LZWU )m"= G3?̈is(]890-Ru'E)wj [^)g+DUN!D";Z}uVBVQ%O#XSHGd ,J+c&U<`J)d rBIA0:ZZE<%[1׾1)6~l7Ҥun1rZ^.-v e.3F1,HhzpTο}Ro!B!#@,wp)+[/wMGs]mփޠ"{ϿAvh]zsB6ltAlN_[GLJޛz1G${>oݲ&jESyM,GŁ7ݿQ{p`r¥zAUї7^LQ} M/Öu`E> d~hb`⟥M ѿ ߫աG(Wr>S͏N|Kwo~OW~G yܛ^kIz\Wgei" 0Φy8Pxe!ӿ >r/O%S"ʑkI}0$8U{ί~#y_7H464_o/lUa.Bxhr ,#.`s2"@ ;dpo"tDB̍e[;| og?rF?~p:/"POFq'do_!,Ӌo0f2Hh8dmƓ.b/?_.>&J/#׫!ݥ~+$ #;=dVDQ:wj!XsC|zU^{+}A;L4<&X rnGx ԽQ\m DB(Gp)2B'D` +`Eh2S5@ $ʗBڼ]f`ТcK;t{;@ůؙ<2HZ,1(X~߾ղataP=p_dJ "(waAW5UDJmDKH3 !S(tNnDeKԺts|.Tp޼kK] fzR26AZoTۥ+(P]g!Vh8,T&2H41-;䓫@uJ"(4Y"׋LEVI<+^H˳}}M}:OrQk.e_m1yȋQ0+Zֳ~#PQb_>Wfw;8Z \>L׌cߑvCOA0.MkNwvwp^din`cn3~{@A<<~3/>h";ez;q0dewKVbyЉt1Y4n5.Dۂw1yp^Xm&$~1%#Ge}{;1 >~lL~U bPvTv8q1nƗ1\|K?]]4/goo^qpl?~ǩ{{wݾ}5?xws_}qm0lWۋ yS~sKkS~1/A<9]n_-^Gj_fo/OͷzyvpJMj?&TS=oo_OE Q7bc^<]H?$?o_p\wvm\K5c.I־?2MFw6< }S η׬ݔ.G`?n5>* .M!pؙ^\tnmվm>/6Ҍ>AqTß~9Ylmkᓷo϶7ߖcWϷۇwmlH٧oڬםۑ_zpexN^Ƣqӻw4<~+ F|n>pZ=}y,q}:X^_oη{ip51@tWF|?_2:mޚ{\w||NF|x{7:@䫱_;}?|i>{u|u4ikAGpuy>FtPS_ﷇ?a}g>׼4foFPSeOS?u|x9yuzc}o_mL_<4 ; ozp|ܞl@X_HwyH!=<{QI?ڵ''3~}xvspl;ip׌tW6}k{K|{C\V? ?޾LhponϽ7}!xxp4m^nxr?u^_<_~y}go}l]~noO'߾w1^|~ټ1_߽tϫw7_/QHg?O#BWaL>}v.no?4߿ťw]|pxL_'G|t~239_wY7NRhEyp28h=k|wο؋{ʗ_}u0 OwשQWft^uCӧoo3ř?ߏmt9{Nwξ]: N/7adv+I&<:o\%>ޝݷƇo-A̩i:_| $|}i{_^z}]:TpԇC'so{؎ߙO=ܽ w߃_k\_pniK8͋ӷG/ywq޼zVut޿͎ճwҷ />4GOQ:7^}[BK^4ۻZ|~;R_;/'Io$>ۜ}|z ՗އ%uQ27kO +/>|3^iTJdzAc[w0H>W׃ Qw~0epuvxx~|4ۛw};pZ ˯óai%R)x}R%`E^5lh7?Ķ d/ :`A:W/'=LLg7NdL8)VGn]",얚wfhUvas]_}.y%'}UN5> e^Us0b yPbJ-ׯo/ ڞ}{,ooorT1%y`\hJ`4jx'e5ɯ^$;x&t Xڶp/q8bd3]4yK壜3S]4Dd9]9̜V`8L "wR< .7gJMl}rl?޶\KXowAN.pK&< *o9y;M/,\`ULZ*UB"ޔg}YH\el2G Ɉ53 [7+Px)ࣰ>Ws׋,3Xl&\:ſn{pq&'܈_Q]}b{ >EzZi+??TM*eNSlswAޱ+طw& Lr8P\3ߊȧt2KwQ|y7 {z?~ޛw%g::h@gw)t^=&[~_Ƥ0N~Gһڥ͆H*œ I)tWf{:$X%2+,{A7p{`+/jVm0I&AP8_u?QWIK"KX_zphp{!iSi/66W747}/qCչss$P뵤UsFwUt|RoNN$vojޏDBQGAX1:MMJV1gԠzV, =W?M;j83cT}g5{{%Ff zۉeo٪ zaw(<ɢיOMEm9eò&ivo1)̻ZG2_[5_QKOf0N"Mh(VW^搪 I BwPg'Un4$iII{ 4h5qyN& S/f+Xi#|;eޘ1T{Z gѴ;ȏ^XshG܍aw &C괾{EF]?J#;ƺS68G;n.]QHmdkgY:|o"_^4f*jz4 peo~KoR߿;.|WZ hIҫׯ5 ޝg=vӀQ͝W4qfic {rka*tR-Iu,l-K9evMY{/PuM@yQhT[3y1V}c`iC/ci0H;Ad8zV6 mV@\g#+|R,D,J=+P{o9Dy0)`h J>N ͣ`IvXK&'(e4U۶L4,\?뙾uFZ-,cXM%Ղͼ ˠN{ןf0wC;3S?\ e "ˤ4D>_.@;c8M](H<݄e:eۃ!Ī/8nҚK~sXF(Z~_,kckM«OWwATSƉ $^ڦ$'1n*N6["&ݬOBG.9-:%r횛Buu1ݕ:Жrϭ7 kXLfV6މڮ ^w͞;bX`bހ4 F?eQOrjM95֒3z6]rUXYE2cyK+{̍h؞3>@ף~>,MIV2X9K&v*!{ zͳd[߬gFb#+ e mljL`]@e$؍ߧ_;?|BIqʪ`5w |ɔXW1Ĭz5˫ !v-,dkXc%@q6]̽\o8 7@ '`k/;*u R%/[m$n&ĿC~ݤFWu84PFuT Sʄw?өO2̼6$?='?S^żIW` COP*/IA(G\!Zx(hj!;`M gekaMtd [I Uȟ`q~Ӌ?iTu DE\$r`rkѺTSж\mhDY`)+!¾;/ٺۛm#7lM{U+pp0v68mI2M]#P0ó"`^a&]=pRhj¿KEG;fr ѭ6'h?^S5Wvo`,azBiZzab>!Zw,";ail>u 1T(V "QCPyw!,xاγUiP`7^#nU`vaydK1W!g3""Gs3%|D!&° {dt"R$2?Hg"UhKWQȒ  +kUD)"ĬT P rUWIh=Au o0f"w ȍ0XSZE+*8رrVc9b6UX0X.܍U1t+'Q=0yBCm)R¹Y !Qiy˅sϝ A)sJB0n;0RQTN 0nFeYoleSآ(2oꝺ*jUeO(vVa ,"5ta8^_ \pRY4&z/ YF+d \ l~UA`o DZu]-Hߵrjv& 񴓢ЁQH,bo CD{"*C⧜NaW)N;[+jUK]32W);JMMAk,%W( IS~\!}h6Wn.axpXyܥ*2stt0X`f ayq3Kw*:cGN德JtyQp A8lt ke*X x;3^Nݣ؍c+RPMxm j♱4%-\F-nNԱrjO.*&ln2!PnߝFÁtfgޠ~='zDAF;4ǹTNMM"HEN '.Z'i `x&*=n6e8ȁMR ,-8l=u?pׅn؂4[+c9D&Ghj:6qF])/a쫇WXT K]8]̜`k 0Ǜ3ò63vp& QVeZ0 p"ڵM,R.tu.6y섮д R] 7ҹogx~vj4r5懗AܙRviu\aQ%Nk( Lƻ5_[ơ=G'T1yB.?'AuI3gcm|j˩NL%#U4*5)oSZNuJ+\/p GOVc, }z oI\dMGj:K@-.bhNt#m:kl5Ks2[.N/ljfLQ4ռK.4 r"nՑyV(Q3b.Z ׁ\(3Xӧf!zBQg)RL67.2v7"1ji`uzq{8~x#-xf2j㷲?#\1?dyj ,7׃F<0܌l^#, -@43E 0] }UxMm&Rs؈'?Xۼ+Xm{p r7wxE^-̷jw=enbtMМC4ᖉn(jt:|͉<{z!jfy'ꆃ -uo{'(S~e+* -Yvys{(fkc4f/eg 3ڵ*h-%?/;7\(HOSgN WPzI("n6 tRUߵh0;ݾmcS;?.UPL) 1uu'TFUj!5^onu9ݮK9ϖxE-Sč „{ M-rk D,7==  uQB_ϝBD` Sx^ט}|މv; (pWK<\X<$,e]jZVo6&`ywd^yd7bz-MZT#JQʁUvO}P`GYgMz.P-㞙jY긾*4'ذ;0Fnͷ_84QGz6F7P&]=oƮh4̣}yBU+WfU#,{Coڛ~W-o ]g⡐KƖFGsun0L ޮt*7'u%|+!oagjDR!ȳS3*iFU +o[qATgHEM+N (Cr*](Nf51O OSY)F{?  y^$^{Ya6_FH_ n}K3 +Q,U,;C–JKo%yL$|p}#4}0LVX )&YGeGIch2D \8" ZҊ ,5@%)7W-{E>h n`ě&ҲzhtVXlCjݙ5 M69muvģ/¼%0C*KocOF^VCOez"D$1?;`6v6ęfޝXzS7ڵ\׍돬Qv”8Rt&\DH`H ?ͩ8]A:sG &QK}O6TRrKµbaLh/$U=IRZU ΢TI"vh%`R&wʑ BjGbGk]aIIJJuIB47ȼ*|sy$Up^dN UE&賅K{Gb4‘w5`- -: yB+Z`Pfol3O MGfI!6#dqzWGx?t]uxn92ף!!$3IJ1? ㈓|FHYCQO&Ap(c?fؐ h?&!%2JFE47a b曟iW^CS -~釹 s; T&9wn6Mo&)ȴ67gz\NԵBdFl`>ll :vr #u *$}xqGd#uA8dA-bH+î,:4BOGN!ORh7u? >}N04v0:.1t:#G/D$6gSoF )1_9nԡw0mA!+8ƦaUu.[h8+&v\NA|urK2J+K)zd4[2oTtCa/(@x~g/@mnHV C7&k4qM1 ۝.{6v`؟ᴀ{Ù6Qr T!3³ʵ$`O #R3*OPe1p͖B[- :|-wHbiR$=N@̓LH[.\^Qمۭ^p{,FVWM!%TgJ׻Yv|q|TUz!z `Ub8N@D!a bGQ&A=bHiP&]GX=hpnFԫ[QT ᗩz񕮥fj'~*,f>_39JEK^U@A^6߳'*&n'AaN{D[ bGei,ҔUog_ hH >N++Ƃ_㪫Jeܙ)r433dЍO*)iAOIA2QNqWf M_Iݑ@}Hd) \6HLOiIxi L7$G:`imVpƃsƋ-q*4=A Tl24~< +8lTߪ=$prz9'au4mF:sC6Ul3V}H${khVk(CMNܬys4(+jK  QBSs; ķroѠ7Ri7+jnԩ(hNo@8тRB74{$RP]HYyO`l@vlHFǘ g`,%JsR&, +{%Tf jDPRϥ%DvMT,o Ng@A< -qP?dfd.!囝+T'Tfp˥6|W\Ffro)ӆSB97*;fiBsr-p], RBRPȠUoP!8m" 0U,] oί7C C)rN3v5HuJS׻AE>xJuE) +=Y!CXJƹBd]@ &i VQQ 0KM3J<3 )[OD/ J?7W8e􈊆xQE̍+,=:u] :˩Ab-(|ebaGeё%GZ7aDpϒ{ ʘM.D5D27LoLF"<ԋ̤Y8s־b$?ߦ ](UFn$#W'42|e h4P"wŃOUT~a>*1ExxaCk39jUedETSj8/$"o=5AU+V|RJL-F _dPz^\--hn$|" L%'Ъz@R&W{/_Hغ wf<ޢ`„Ap̓w{۫ bio]694§/XBVEpId0:VsgG|S6$t(;U GwI tNTKoh,A1i|̵[aS/-ӄG)4bWD$͑B'n=kË9 /!܉[y/ Z.-W1&:b@/rqZ|\pGȚ鞀lܡp>| L\M-9K.-Ex7]W˱v070؛(dmjܕVFG1ej6Gulo( {TIb^ sMSF 59\st[+1{)َ'[el׀3tz:Bea!$ #d t|}*Bǀ%9"{{57ڸQtRY3tۻ; " v9WJXHGs[p~X2nBv=뵸IT?'DZ+Key,T(L۶c O [pP} U,D*b첥e# Q9bu"1TJxYĈQYD-hbq;1Yԋ\fr,RzsIOI/#"Z4t,u5b:Kg+1ʉsg64cbREAyRb@ϮM- kiGdy;(2-.3 )MVmɵybD GfKxS5|pbeƏ$¸q.4 |a*_/Khw_]WLNRRPQZ3-kI]>%?잔[T{~DY]JK%l--Ko-;ipAGNdz;CYدjÒ'nط'"kSYd#] S7wn /]?nЗH ^i,_ѐh[_ZEFNtG]0RԡUYFacnArO Q,,a\s5Ur7Q^2tY̜M=U:*( < %z:Q %N kcs=y{a3*'6A{!,E4yo6`މa {{cWo%̝XN5Kuv'EfYs(p:Qެm1M*._vebztbIط˕ ( i>#_?]aTyQDHd?p0G3\M#f4a8s(]d`Zn+v3E2q@]))t`"w "aߥz +N^D/DL6J)J۳OId8sƙ5hp:feRuc$Yg% B,7Iu.' m`_hcpS;icEHÃS.:vXGr>ˌMGF0k``]c5`򝾞x6 kܕ={DGXkf訴Vvę &,*vmi8]q!{]u :Y;Wþ3A AXGob&go{{{TJ0qTpZ5FM`ԈȈwcϭ(`ZƅmIAMCwW|3h݄wJm.{T@XlU S&)p6iա" |(4wG)?+cXacR/Zu 81C]G.q͏aEč_~ݶb Z-?Ł871%%߿) r@𕃡͐jֆ`EzWǯ6[diG>^PHTF>LUYU.ɢkd5!qr^xiV6i38X4x-R;7"`Ul#CV}Miҧ1 ;raOBORL2r4(MñAK!uJJ|1AleeQ"vh*yLCp(B9Fl\GfI+ Im1_gY;4(/dpJWf# k`U/u/)?YU ojCugX2HX56' _(4ݡ[bl wsZ/8ƴ;)GN䀟mlL5ʅYבؠ,AD'0qzQ(SYZ0Q_Zn_?代f±٢X^jhAYk D cKeCs>]*j}ǖ᯽X$<)ГułzP{?wk6 /øRO[7UY8J]9KK6O_њՂzqt., P±k y>+g؄ڸq ĤzV;DZ@ġgj&Nu-8`|zy^dQ&!?/A89諁cV/>Pтm:lÂehݏ|uRg{{Ro˙g_y$q]!zQmPR FmaMV+,"(9F\^xܐ w>y+efҟ#gj(XBuU-=R5<TsS*:5#JV5np6Bwkz)Y V&< Е SnSN-}扻E+ Z⮟mi^-l0$_. lʸLBKI,"8'C`r{!Ig9ӔQ,憶I,{M`rTh86h}7>EM]Y[ǚ8٨%!NN!cU9"#-۲s3n8@nz9e1У(Yo6u s-{0 ^rTa@9,֪s6fi"6&_a'tHtPt2!_y92 ӑ[B-FUhԴ‰1U s0ND"W A, ȁiSwi֙\*\q".G#Tf۵Nƙgq (M,̔rj/ U7[0`ot</3qF|yXѨd&ӡ0מ2޹T2FMǶz:-Pt 6`1簕/NYB@± s`aOe^M(|2{(3<<bܠyF}OPNFJktg[C7sKT&쮞x= W nn-oCe@+]!;¡7p&ahMIFT9єLeMx CI(m { \ˣ4SdX8NY&GxXÞcIh5vd`4Tz~Zp˱; 3l`^q+2˪Tܗ+,<p1P3OĿDN$"j`x~'1g3&ݝq r! ׭gRwb1k3B4!h>9I7eg>toƽ&WG-NJ\係^&Y"98]A.砂P*c`jd&3FIf *h5l^ .>y&Ѥj~ 32CpNFCM@f3] H s5*Sa"TAZyOy}( eе8:5reh`o-j%~9yǗX`{*K Kw,*Kk@e<溨h|Y@XjJ?-}G$T%FύDŽ Y!QN??׀'ځ^n09w'*2r-'f&(ݓ#S۵^2֧,]ΕAiGq8wDqo$ӹ!GQqhdFm[9yO Tbiגq#6\9)l<v,sЃSlv*jVIRJa^b ZEz0 _AIKMnIݺQ/HrU֏Dz(n4{,&[M\WF6w5 u +G5n kxrDQ*ڦe\)irB$ LXz'Bs%!5Kt[`폰 kIxQwl\j`uW(>ODVb_K̵{tWܠ%iԱ껳i\3OJ,}no&:`eF(ȟ PwQn3vIJz BG:vf'#s QJ3O߱Lj eF!xRxU+|afTЧrXc pyk"VݠkCAQ*S@)LUȃz; v՛vy͇xLMGr 8h'WmcQr]Yv?ֲ(zOkz;Fv|yaY;~4>'ГȖ~2!"$ ((2g ](nNSc.fJ 4V:I7w4=}DzmϷSqX՛#@#{BOhm䁊a &Pmh@CGv-:NuZTgix”<4OX]M U.80t!Vn&]5NL/xz*jqx-~m"$Ez,/_I'nDJ8ؓxBͩىNtXu-=?sr8si.};zAZ4uQα3'*[z<⺯y%Nj#JqqԵBTIWu2 >}r@n^;A|w%* =G4j|0ŝCQaZ%k]zļ79Myt_2XfI-=6سYu/ce3r1v^XÅ{JT<499tp]"Y 2v?_*t`zm(e^7OK<\#OEt@{eD8% !A3싍X]$s=&&#x؆Zr/%,ԋvcs#ĹJ2x%@kRQHA*CDML-;q<ňN!n%񷮍hVOuM06TLHo1<`zu L&0cŪTyNy_!W(qv;o䶀:#ui2mv;ei`O|ltCc\i"#$B\ݵgXh$J⮉3ro! cNBJk¿Kl2Śiobdu|ӒjT]}_ lZ.*4A !<ңp^?ќMB:b:Et(E~-<<2`>G÷իibΝVM%Ǡ1Ǜ(p:׼I/n#4ogImSNMJIff50ed}lakDC$ @~T6XtgJ^-* ődwF8ßqH(F.~wY#^[lG:Bh9F SVMc>6zQxK -n:95&w"0qqqL_*Ld}yj0＊ Qî]iRg2\nƭ͉p]wM5Q䆴c"Sp緺ZHY~LU˪ǔ$\xf]qbHtt ;&gyH14 ulW?i#2Ƥ_OBE"TlL&KT:\Ѭrqצ$?5[wZ%w7YZ$˹\ӮI H&]=a!q}UK*'wu0AOd.%F3)U=<.4AJNJ_;VI7pvJ3rYEky35AD 6 <{w6$200]˲0z_f\@Z+K7Q;Ù5B~xeidn|l6F2Rщ-d9j'fg3Y,'[~^nе'-^NnǁNbyJgzPZm7FHK@k@$Dʥ]k4yU"hhd5AXV)sn x9FQyXJJ\|L*ZVz~XMӊR:$%sy v1[1+D4wt(KʏЧ`pG(~@~w??6h઱frrk*-op~R %oG܃6g'>2B,s&hZž_)twXi8]fmYo[Sݣ`4JWJfY9ݤ~| f%ݭi˅ꆻ͡Լ|-(k^mre0]*OgGcS~9@zdZԛ3}Z.'\ké2}ul"ׇiFk+]KbNF4OqB,{'K+f X*daF[HY*<`s*` B]^؋ u}R>6cO< 0wzqSc s|bΖ3IôcXø'zH{ajESG5 QחL,7`L;c_a6aHp0{ .c`uZ{@OI'³Rǡ `-Civkyt7L] c`hrr=R{u4Jb_ڴמm؊kFoz״ ]@K*fux$@S+0`~1~Βֽ!2QYV* [hO"Z1Vy`WCMޕyUrpŁuƴ2/y "Zb%;ԝLQH_/K:A樌^fc]:j"L>O|jQZ.m+7Ы `$eUz:įO&E3:Q*MhT`۶'d<憙lQ]k9qc1t*Q(Ў]/\bꉦ3VsZ|m1Hm8_8.Y>XMy .կY٦nUDHXϡNs &>,-K-IvE噧qJ:嵸~qdWԒ`9bb'YLdUƊ\D7ȹ*HgƎml|񳦊vڎx S ܁M PڽJ<Ͼ )4]"G_¾Ld&jvNiq{̝Dka6BD,<%dCV_E FJ8 hH<=,1 Ex^g"эj=68R#4 涥-~INGpdm:,h?ė#C@n$)8X`l[-ADBэBG(@M׊pzgV5֥U"ͳvֽu)Jnj8*M<$8 3 -7<.Дu3JrӐ_X{z& ťN0,is uQXvDP*0ddq #?ڧĞPRCAeN v TV_dwĎ TG<5`%=5=n(zȯx];h xrʺf8UX׳pV ׎ל:@p`tRS?a¶籗mxeUFR/wpG1 ]m G4dԵKmn{2KN$̵ZdZjpP m"ljnG)WYƹDmtℹ4F+0_WF}~pc4WGÙFEjԡi) N~(wґ\L[$02 ЍW- 28&9.ڒZe[$+v*|ܪc-p,?td,f>gQ6&.j82I~Pr~m|OJ+N5D%c&n{T &LB@9^U~+2?T(/!C{EBa>WA#m(j2 ~7ML<&/- ֦슠/=knFWxRMN@t.sfӴӏ,}d$(` 2sgEI}1 c.1qDF}6Hd\qO#(HQ:,g2H<P^7v፪]LIAԤʣ`[U2R=b[˜|}(u}Oi7qRF#={khz=`!*RR,N٢*)t+lr,cB;AodFyj]}}3Mh> ֠tz E6 OV'T{BVUĐ% pIj &:0h׆QIiO 5N3eZRbAC}uWS " u:& WiwqP# ŝRiL˄2OJLFVv%Ϊ'&eE*[6_gYl >aIaP8V 8z-^̂ꅒRܐNaR:m\du%G魆$fr7 &C4E YM4]::Σ6W,ghZFh"C ^Ze9 v_ݔZU;ł?@i7En^x?alJ>JF>ƌLZ.Qt<7uSZt1r=XvS6=m`dv l|ŇGȇ/_'!2nMmRps:w"x:(G;GD7 -8iGjpBciqrC/S # z+Y]=9aV<ދ_n8u @: S ngVw y#-vegAlTxJlc)O|\D #g;CuSj>N`fvG0s t² Xen sXB9Q;zYdl;MהSf9RpL'\M=qJCje]s;bXˈg-n=y.J+:;j gi-˅#@%Y=:MbP_O ͢+:-(]ӂZ5{:̅̆ *l*RU!Ȕm /s͗Yn*g[6r-2%Zx!-x/۲#2m ʈ2q2~'Cse)I% 5Se{1Fé:Ҝu'L`ue9gl=ȆSFIC皑* mX)TW`hSl>/'`Ji7k%}ݑd{^f.H9*. q?YP >64,\?뙾uFZ)JRꎣ46EXGs-2_VIE ʲ8aqHd4s?\;!V/J{J4OÙެ<;5N3f$ˁ33h aj \-@Jzǁ% zkI˵) ͌\lHE36,팘"N!,WlxbݍxZːBv 5E8D6 c5:ݾtWE]iipm1SwTru™Ne ' A>\&{J[ۥJ} .Zۯ#C*<hUSs[(2}(SG?FIIX"i&Л jqwuVra[dX0O sUp$gv )s6QP"4=l?"zkkt):)(8.컛uu^ s@3cq~ <_V وf(@"AwH/h#.!0*UNP7a8=G+,Y-,:bnFzPXE 'fS 6+d%$8j+lj%'xOMU-mijHNV(eϋ?ps16Aޜ8"kˎi~iO$^;-tuUXjE8P`c4K#QA)Δ$UWf!Sf,Y-P%tda#M@8 soWGM``.=b)s s0T&^ \#+W@?1=gfxSukOD`!CB=%1ͻVq -=qQ>\ U& S9`\t@Vr~*4.tFXF~ţDΘhX_Vv?ƬXս+.1  =rǬm\ fh4U; BzلI"M\U;ܣ<V" .ηL3JNv͖ G. ܔd_Ytb}F+;2kz%_di0pZ~0Rx #$B6p"#1Ǫ$VEXq 0q*.&rN )?~~b4"hOWMG̹P:|B*rHFHuqݛr&jF" -%{> U$o nԍ%JY Gr2Շ͗dR5 }lm}&iL7X4K`rC>'R ,b6_j,84]Sf3Ls'D!4ylGxgf0{x5 "=UVoI1($*EgïQu&%<L[9:TI&ѼJќ-G+xA >-=TߥEq 𪇘"*!n6u\ NFqHBL0(jjM)VS tuL YzSuTF|! x4kp;fA@ }{Z6Z.u0LlO 4}ب'īN矋~t^Dϟwy{?:xDe?p+dmj2@-ٸW" Q:$ԟL؆t eNF)8)@Fn ]ɂwi/<x 4Nt3Ss"2`{Lzh#k:5 _k_qv1%w1EtIgdOfފc $]^^xnz g{5`L9 JgA`&|bz~S}e~6`^^B4}pCt7 1/DRl iVgߕ3@\ |#oP+"o)\|9{$^@jY/ج*э8N[wQyd;0)`S${`WtOq➒7oĨ52JYۦ޵XqT6. UAΤ638f1~YFnSQ;yL*Vqtޙ )v`ðT_~_yQaC4Ѕ7<)+: &eF"z.ēߺZj7C aP/KgLQ<D/@kP!1މo꫙@-1*0?׍Qi `}ZE"!H)%j Ze:86{sҋA-RRԟ> dkǺ5# cQ/XSJ{lZlÒgH(t;V}Vo0%>ǵHU L VRȏ"멍)j96\U;au6HxFdHVD o7 ,;s(w|D ]wʬU:q܅|=?8]d#Ow33.ce[5bh%a`ҤM$CCkAE2S̓b?ebYѢ%haOTg)[5 ɣnjV&NzN2'e|d-QY 7Z?}ᰄu4]#u)pS7 '"@I,9}t /:YX4^P j.`ʳ®kfr%BM ,*F=,&;0K4ثB yW;ّiǽ~Ux,8` f"SEt֬:im˓C]Z&?U ]ȞVBJ"cՓoV*$xD/G tK$6ȍ:fa8pB{o%:2ښ/,B*<=^O6l˧C+bivɉusZ%;Ҫ9\ҚxG~뉼7EW.r4MgvjCRe^_i3ZE'Gꀿ9LF uH:

М) =ڳ< =zTKb/E~dMy:~s\hyp6U\Н(EܰQ<#,fa2/T*)ȎXfnQ N})꼇*W74H~p0>3l_=Pd^-~v"1GLf”f;},BAG{2 ?/Q .zIAT }* C%:KNYhF.zFVګ3{~^ıF/kpfׅcԥ{FSH%0ns f^̖SdkN;ʻ%TrZ`2 R@VɼnbBC75_e`244ϦӺZ<LպD PyFQOV}i#7K 3_,el3AFn$>E $W#ݗH"Rx,ӒSx.+'ss;lqxxN.' ij m/4dT|Xnʳ k5mO)Gy[m<;cTBPt={EidҫMҢ2;")ivh@#=<v9'5͵˕҉LL(߃ a$t%s/ŚAO_*ͣ3Feu`E,K!|ӏ/bs(e_4 Ol%OlH{DUzXgƦJm}NtA odŦ!~5o[JxZowWy@΄.}?k͇m֟ &,eƁڃ4@yl@[ƲO>Rv uŝ.Mnn9Ԉ$> [Q+†O6xM,6uN4ABG(bSgJƤN#,ϓ>!a9d,'H0=}ZUqI߹EGBb+t'k@\%ہ)[ 4yG r}߀GLs7 y#EomitdQDSw /zyߕ]Gmke۩},S:䃄Jx,9Gj?[[Ti%8-Ub4$ B%$8BH7Vot:&>#|gM2f1 ہ*Do_;[1N}}=kvv <?UsُYcпh_bªY# =Hg JQcÝ0Fo> >*H~mTHDo4^~{??U豋[A>Nפk/Q[dFqqA T'F /S磖$.b!dSK}:hw!uw*XUst\֜>;l8Ѷ:bPW+Akl<0.`9"a:efӝř7$oh< ,u *"6$ֳ+3QGG7_}|H1tҍtJ(֨=O{`CN-Q̆wCO5 [Tpõ7^VeӐ!\5˻1qhLAІ>nK $Jn}F٧t0etY]~AU 1Sv9PK9 'ƙ'sYorZ-j`lQ~0T[8sͦ,QBvQUChRњ4XAl<}i ƪ@3r(b0f9xmz[lT6#gHfMf~:Z(pJs|Oم^bݞ }/᧟}#᧟#H}ϼ bK }=A\" @-mʀqwۺNqZ.tڸ (WX0I3Qg.~u~6Ab FCP1~yV؈Bby,- H;S/Z3m?J\יH_#߼w 6xt|yzX|3ᘝi[+XC0p~jGYꈒ^zϽ,_谻h?[R_v(YciSoծ5ʝIr{  Tx-̀oP-F^dK^ed0c0f|!|(/{r={2g_6IW d%E?pGm:r6" bxyzHf&LVnز[OHehxM"MUdP> 5TJ˭/M5Ǽ8 Iuk봴}gg{^=w:2f8tS[~mfüI-xN2A38ׁi6(J{I֣Mc- !T:ȭNH=Ic@D 1^!pp^[f^60БQuQDufS2P ? +[Zڹ^zfJGqA(tKߙYƫ+_:ZZ )t\t 0>)g_ϑ)/?[& Xd"5YWC:Q؜NZnzG,"ʥѫKSf2%zE:륷!P(M˷0 MyA1!EzB0=2%ozW2.kz(% 9pt&Ų1,"M͓os"˯T=sӖFÕ7y,xZ ~I\XeJz;H-Gm3MSMj4uXrX~]< Ұ*F>$(!L Xesa!gQ [¸1l'a.[ك[M.xAd8w& y,HY˨ud_f$NЫc a9e_$+P.LW c%愘 u}c㸜G 8#}h1FMpԸXU-sWFV:.WVHGo"cA)NU<}R)6PC*/Q9}w<:wk{*O:?t"r6|iNWI$ꁡ ` t"2n4=L<$q#pyMϖSnvTRdtu봩gw/}k[]'hQsO"}h pn y䘶VX_(жlGŖٖz kX `^'#Wsmqnz(06~6IOi*A:aE=I\6jD,;9pr]ؙL' wEjI"jQ-ӟi 5>h4M1E3pc1diBS\lj_/ی8  pqt~A)f@h ǁ\Fz\BVc ,)ɩS>\U[@ -X˫ݥڜՁyghDG8 >Yċ'zEI ʹdBbH?nVJj_t [`=7S\DF[S:LQ ےCvK gѨlEefyaKI B,zte|Hd'M-ugզd\6sv0֏jDt>y:}SYul}΅-tYr"40SW塽PUw n׮k}|ނpK\ | 6r .je4($[sګ_P)m5lӉYYR0ŠB[8"I<CQJCJ耵ha%ͺKhgtlF=ØgTa &\)ܐӍ'X?l].κ\ػMpL$;DcpN]1I9TGG~k>΢uygS1ܝgGļ*,?i7; b,S낊T^FS,yg8e}.eZWv.7Dڑv)5ܽߴ&AAOBaEce0tIX$SЖt]ʧX :hÉ# ƫͩt4z1^uZ_5W&a,lۘD-+k/Fkgy*izmqS |$ao3g+mm"y`S}8b tE֨1ɲ8;u| x^ZfK*# &HUGwE?_$x5'zbc1C{nBݭ H? lP,J ,c_ƻPu[TM,xcK?  C S,eܪ]nuIJ6޴AϧxaɸmdE%}x)& 'EPXZ`ei2Kq1'No )%rQ+YzӼ5z_|}9e"I#:5ey`1>[B~֘&CSB#]MfZO韟gY`ƻ4[g}b%~XV!Kkjb<ՙVJeB+yp{d)z]w]xh&W{w:q&=L'CU?%j-LOŹhc!i6׍x ׈PglJ;~$C^A6ȼ4ÚŅQNNU% ô#{^\+6z 6@;BY)!vd˦zdm/̱cSvdGXJ4}M֥ =He H ad% Ơz7 z-"ٜ߭t}Y8^O9ANb6Þ6P׾Z #+]|:}uA(܇Եor,nG@掭.AR9U!s[AwI#$5C-A:}}l3bP7@Ab9sWL6\ZT-el/v˃u:aߝ&dMnN}Y1߬iNq $Cw 7( A]а߱ZAv4d^% ⟳|KVј&iqf@0AL:G(莏&s0UeПogLsj+byvuo%~PWzmϝrʐT%YSpJ”I/mM}ɦ͡ΌtuZ8 f06g]9*D݇]d1_43>deo 2f '$jCq^e;Jcc "Jǎ5\Soes4,ګ۸FD}p[=}NO0(IRK洚|@m,]u}=V+ f*W *}5w ,ý#'Ǵ. d Q6E:KzJs%Մƥvg_%ȼJ&G8.Fq:ɧ# tf $d& 7n<'u*+J/^X]"605| 4P&8,p,gL&\i~0ow7>?}&wd:<.&"6/fyah{'Eli6tv,`g(CD$Imi ²ۭЙI菜0|p챈Օ_σE~aj)s͜&YVVpY:;:ń &!67hp~7m]%x"%J8~Q j;ͩfȬF/U(gwfuX0?ңO۸D_Fj=(Fx֬$#}-|".ԠuYT4V683~}ȉ^@Wbה99Ujꔻ{^8/c?&:6Y,['aDZK2=1Fk\S: ,ISA UNDo ރXx%I:!.0V'U|Mn&5jos.*Bjiɋ!I -nrɊd E$ƘY H?58/$a(*i`Ӧpvu r>Xe<^tm?|o:PMIt`ZgQzSiM.)U[z#I$'@5(R?8ɓݽ N(h|8l$Pl9(#mݔ>-(+mZ ˀR#DƘgASM=br4MlxEqzw 6pu[u~VV-(n"^6׍_m[<4x+U νk?DMxE1Tze}mw0wP>YAb KGisZ^vU"ݾhy.!QaKJ`8# '&bq\|:qGc0HO]: 7zZ0of2X_{]52%2/'V1Fxzɓ-)ZЍu3"c#3s'-泴,;= Vpz6-Jo ]'^gho<*Z Aq6*vOO2i6>A*LMZsΐVQhL:=]#[dy=Gʧ٦#BWW[[ yAtV1f$Ѯ ݢ8D*kl rߺ/mzMa 7msڝi5.\ԝFHrGRp_}@}T&J?/w+z8̼=3W|U̜ypl"W5²"<dmzJx0 -|-E) pؾIbRKfF0\$Jg+ Gw`“4X ;/ ƧݞY> ƚ(GJd`] 9:fq߰ⲱ}W|:-j R5Bk4*smsU(BN"pMm@ȝEҪ&̵f0VgKuE<ݬ]qe'M7|\ҹ9OΡ/gq=]^E\,9Rr_շo, ۖӑwj]n.[zO=ۢuZPѰHUVՂPu-e:9oAQ1c Cliniversity https://www.cliniversity.com/ Innovations in Learning Experience - Cliniversity Fri, 07 Nov 2025 12:40:23 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.4 https://www.cliniversity.com/wp-content/uploads/2025/05/cropped-favicon-Clini-32x32.png Cliniversity https://www.cliniversity.com/ 32 32 Good Clinical Practice (GCP): Ethical and High-Quality Clinical Research https://www.cliniversity.com/good-clinical-practice-gcp-guidelines-clinical-research/ https://www.cliniversity.com/good-clinical-practice-gcp-guidelines-clinical-research/#respond Thu, 18 Sep 2025 00:47:00 +0000 https://cliniversity.com/?p=4993 Good Clinical Practice (GCP) represents an internationally accepted set of ethical and scientific quality standards that govern the planning, conduct, documentation, and reporting of clinical research. Following these principles is essential for safeguarding the rights and well-being of participants, maintaining the integrity of study data, and ultimately advancing medical knowledge. Although the value of GCP […]

The post Good Clinical Practice (GCP): Ethical and High-Quality Clinical Research appeared first on Cliniversity.

]]> Good Clinical Practice (GCP) represents an internationally accepted set of ethical and scientific quality standards that govern the planning, conduct, documentation, and reporting of clinical research. Following these principles is essential for safeguarding the rights and well-being of participants, maintaining the integrity of study data, and ultimately advancing medical knowledge.

Although the value of GCP is widely acknowledged, achieving consistent compliance across clinical trials continues to challenge many organisations. This article offers a clear and practical overview of GCP guidelines—their importance, key principles, and strategies for effective implementation—so stakeholders can strengthen their commitment to ethical, high-quality research.

What GCP Guidelines Cover

GCP guidelines provide a common framework for designing, conducting, recording, and analysing clinical trials involving human participants.

They ensure:

  • Protection of participants through informed consent and ethical oversight
  • Integrity of data via robust record-keeping and transparent reporting
  • Independent review by ethics committees and regulators

Compliance with GCP not only protects human subjects but also enhances the credibility and reproducibility of trial results. While the International Council for Harmonisation (ICH) sets a global benchmark for GCP, many countries impose additional local requirements that must be understood and met.

Why GCP Compliance Matters

Staying true to GCP delivers far-reaching benefits:

  • Enhanced patient safety and trust among healthcare professionals
  • Accelerated regulatory approvals and smoother drug development
  • Improved organisational reputation and investor confidence

For clinical research organisations, GCP is not just a regulatory checkbox; it is an operational culture that demonstrates a genuine commitment to ethical science.

Common Challenges in Achieving GCP Compliance

Budget constraints, limited manpower, evolving regulations, and increasingly complex trial designs can all impede adherence to GCP. Yet non-compliance brings serious consequences—from regulatory penalties to reputational damage and, most importantly, risks to patient safety.
Organisations must adopt proactive, system-wide measures to mitigate these risks and embed quality at every stage of the trial lifecycle.

Strategies for Strengthening GCP Adherence

  • Implement robust quality management systems
  • Conduct regular internal audits and training
  • Leverage technology such as electronic data capture (EDC) and clinical trial management systems (CTMS)
  • Foster a culture of continuous improvement and accountability across teams

GCP Compliance as a Business Advantage

Meeting GCP requirements is more than a legal obligation; it is a strategic differentiator. Demonstrating strong compliance can reduce development timelines, attract partners, and open doors to new markets.
Cliniversity offers tailored GCP training modules and advisory support to help organisations integrate best practices into their operations and achieve both scientific and commercial goals.

Conclusion

Good Clinical Practice is the backbone of ethical, reliable, and impactful clinical research. By investing in well-designed training programmes and quality systems, organisations can protect participants, ensure data integrity, and maintain the confidence of regulators, healthcare professionals, and the public.

At Cliniversity, we are committed to equipping professionals and organisations with the knowledge and skills needed to achieve GCP excellence. To learn more about our training and advisory solutions, reach out to our team today.

Call us to know more about the programs : 7676838731

The post Good Clinical Practice (GCP): Ethical and High-Quality Clinical Research appeared first on Cliniversity.

]]> https://www.cliniversity.com/good-clinical-practice-gcp-guidelines-clinical-research/feed/ 0 Best Practices for Data Accuracy and Regulatory Compliance in Clinical Data Management https://www.cliniversity.com/clinical-data-management-best-practices-gcp-fda-ema/ https://www.cliniversity.com/clinical-data-management-best-practices-gcp-fda-ema/#respond Fri, 12 Sep 2025 10:41:00 +0000 https://cliniversity.com/?p=4947 In today’s fast-paced healthcare and pharmaceutical industry, Clinical Data Management (CDM) plays a crucial role in ensuring the success of clinical trials. For students aspiring to build a career in this field, understanding the importance of data accuracy, Good Clinical Practice (GCP), and global regulatory compliance (FDA, EMA, ICH-GCP) is essential. Accurate, reliable, and compliant […]

The post Best Practices for Data Accuracy and Regulatory Compliance in Clinical Data Management appeared first on Cliniversity.

]]> In today’s fast-paced healthcare and pharmaceutical industry, Clinical Data Management (CDM) plays a crucial role in ensuring the success of clinical trials. For students aspiring to build a career in this field, understanding the importance of data accuracy, Good Clinical Practice (GCP), and global regulatory compliance (FDA, EMA, ICH-GCP) is essential.

Accurate, reliable, and compliant data not only ensures patient safety but also builds trust with regulators and sponsors. This article explores the best practices in maintaining data quality and regulatory compliance, while also offering insights into how students can prepare themselves for careers in this exciting domain.

Why Data Accuracy Matters in Clinical Trials

Every clinical trial generates large volumes of data. If the data is incomplete, inconsistent, or inaccurate, it can:

  • Delay regulatory approvals.
  • Compromise patient safety.
  • Lead to costly re-trials.
  • Damage the credibility of the sponsor and research team.

As future CDM professionals, students must recognize that data accuracy is the backbone of evidence-based medicine. Learning how to manage and verify data early in your career gives you a strong advantage in the job market.

Understanding GCP and Regulatory Guidelines

Before diving into best practices, it’s important to understand the regulatory frameworks that govern clinical research:

  • GCP (Good Clinical Practice): A global ethical and scientific quality standard for designing, conducting, recording, and reporting trials involving human participants.
  • FDA (Food and Drug Administration – USA): Sets strict requirements for trial data submitted for drug/device approval.
  • EMA (European Medicines Agency – EU): Regulates medicinal products in Europe and aligns with ICH-GCP guidelines.
  • ICH-GCP (International Council for Harmonisation): Provides unified standards followed by regulatory bodies worldwide.

For students, gaining familiarity with these guidelines is not only essential for exams and certifications but also for real-world applications in data management roles.

Best Practices for Ensuring Data Accuracy and Compliance

1. Thorough Data Validation

Validation checks must be applied at every stage of data collection. Tools like edit checks, range checks, and consistency checks help ensure that data entries are logical, within range, and free from duplication.

Tip: Learn to design and apply validation rules in Electronic Data Capture (EDC) systems such as Medidata Rave, Oracle Clinical, or REDCap.

2. Adherence to SOPs

SOPs act as the backbone of clinical research activities. Following documented procedures ensures uniformity, reduces errors, and enhances compliance.

Tip: During internships or academic projects, make it a habit to document every process step. This discipline is highly valued by employers.

3. Regular Data Audits and Quality Checks

Audits help identify errors early. Independent monitoring ensures the trial’s integrity and reduces the risk of regulatory findings.

Tip: Volunteer for mock audits or case studies during your training / internships. Understanding how auditors evaluate data will give you a career edge.

4. Robust Training in GCP Principles

Every individual handling clinical data must be well-trained in GCP. Training enhances awareness about patient rights, trial ethics, and data confidentiality.

Tip: Enroll in GCP certification programs during your academic journey. This not only strengthens your resume but also signals your seriousness to potential employers.

5. Secure Data Handling and Confidentiality

Data security is a non-negotiable part of compliance. Access must be role-based, and sensitive data must always be encrypted.

Tip: Familiarize yourself with Part 11 compliance, which governs electronic records and signatures.

6. Effective Use of EDC Systems

Modern clinical trials use electronic platforms for faster and more accurate data capture. Knowing how to navigate these systems increases efficiency and reduces manual errors.

Tip: Hands-on practice with EDC platforms is one of the most practical skills you can add to your portfolio.

7. Clear Communication Among Teams

Clinical trials involve multiple stakeholders—sponsors, CROs, investigators, and data managers. Poor communication can lead to discrepancies and errors.

Tip: Build strong soft skills such as report writing, documentation, and cross-functional collaboration during your training.

8. Staying Updated with Regulatory Changes

Regulatory guidelines evolve with time. Professionals must stay updated with the latest requirements from FDA, EMA, and ICH.

Student Tip: Follow updates from regulatory websites, webinars, and professional communities like CDISC

How Students Can Build a Strong Foundation

For students aspiring to enter CDM, here’s how to prepare effectively:

  • Pursue specialized training programs in Clinical Data Management, and regulatory affairs.
  • Work on case studies that simulate real-world data management challenges.
  • Stay curious about emerging technologies like Artificial Intelligence, machine learning, and blockchain in clinical research.
  • Network with professionals through LinkedIn and industry events to understand career pathways.

Career Scope in Clinical Data Management

CDM offers diverse career opportunities such as:

  • Clinical Data Coordinator
  • Data Quality Analyst
  • Clinical Database Programmer
  • Clinical Data Manager
  • Regulatory Compliance Specialist

With the growing demand for drug development and global trials, the need for skilled CDM professionals is increasing rapidly.

Conclusion

Maintaining data accuracy, adhering to GCP, and ensuring compliance with FDA, EMA, and ICH-GCP guidelines are non-negotiable responsibilities in clinical research. For students, these are not just theoretical concepts but essential skills that pave the way to rewarding careers.

If you’re passionate about healthcare, data, and making a difference in global medicine, Clinical Data Management is an excellent career path.

Ready to Build Your Career in Clinical Data Management?

At Cliniversity, we provide student-focused training programs designed to equip you with the knowledge and skills needed to thrive in the clinical research industry. From mastering principles to gaining hands-on experience with EDC tools, our courses bridge the gap between academics and industry requirements.

Start your journey today with Cliniversity and shape your future in Clinical Data Management.

Call Now : 7676838731

The post Best Practices for Data Accuracy and Regulatory Compliance in Clinical Data Management appeared first on Cliniversity.

]]> https://www.cliniversity.com/clinical-data-management-best-practices-gcp-fda-ema/feed/ 0 Regulatory Affairs: Building a Future-Proof Career in Pharma & Clinical Research https://www.cliniversity.com/regulatory-affairs-careers-india/ https://www.cliniversity.com/regulatory-affairs-careers-india/#respond Fri, 05 Sep 2025 07:53:00 +0000 https://cliniversity.com/?p=4912 Before a new medicine reaches our hands, it passes through hundreds of checkpoints, thousands of pages of documentation, and months of dialogue with authorities across the world. This invisible but essential journey is guided by one discipline: Regulatory Affairs (RA). Most people outside the industry have never heard of RA. Yet, without it, no vaccine, […]

The post Regulatory Affairs: Building a Future-Proof Career in Pharma & Clinical Research appeared first on Cliniversity.

]]> Before a new medicine reaches our hands, it passes through hundreds of checkpoints, thousands of pages of documentation, and months of dialogue with authorities across the world. This invisible but essential journey is guided by one discipline: Regulatory Affairs (RA).

Most people outside the industry have never heard of RA. Yet, without it, no vaccine, drug, or device would ever reach a hospital or pharmacy shelf. For life science graduates who want a career with both purpose and stability, RA represents an extraordinary opportunity – and one that is expanding rapidly in India.

What Exactly Is Regulatory Affairs?

Regulatory Affairs professionals sit at the intersection of science, law, and ethics. They:

  • Interpret guidelines from agencies like the FDA, EMA, and CDSCO.
  • Compile and submit clinical trial and marketing approval dossiers.
  • Monitor products after launch to ensure ongoing safety and compliance.
  • Advise research and commercial teams on evolving regulations.

RA in drug development s basically involves : coordinating scientists, business leaders, and regulators to ensure every launch is safe and legal.

Why RA Careers Are Booming in India

India has become a global hub for generics, vaccines, and clinical trials. Every new plant, trial, and export order creates a need for trained RA professionals. Companies are looking for people who can:

  • Handle complex, detail-heavy documentation.
  • Communicate effectively with multiple stakeholders.
  • Stay ahead of shifting global standards such as ICH-GCP and eCTD submissions.

Because these skills are transferable worldwide, RA is one of the few life-science career paths that offers both domestic demand and international mobility.

The Skill Set That Sets You Apart

Success in Regulatory Affairs demands more than just memorising guidelines. It requires:

  • A working knowledge of drug development and clinical trial processes.
  • Strong scientific literacy combined with legal awareness.
  • Excellent writing skills for clear, accurate regulatory documents.
  • Professional communication for regulators, colleagues, and auditors alike.

Graduates who develop these skills stand out immediately in interviews ..

How Cliniversity Prepares You for RA Roles

At Cliniversity, we’ve designed our Regulatory Affairs modules to mirror the realities of the job. Learners don’t just hear about dossiers; they build them. They don’t just read about inspections; they practise responding to mock audits. Highlights include:

  • Case-based learning: Simulated demo submissions and variation filings.
  • Mentorship: Sessions with seasoned RA professionals who have experienced in INDs, NDAs, and global variations.
  • Communication training: Writing persuasive regulatory emails and presenting to authorities.
  • Career support: Interview preparation, resume feedback, and continuous LMS access for updates.

This mix of technical knowledge, real-world application, and soft skills produces graduates who are genuinely job-ready — not just certificate-holders.

Career Pathways After Training

Typical entry points are Regulatory Affairs Associate or Executive roles in pharma, CROs, or medical device companies. With experience, professionals can move into:

  • Regulatory Strategist or Specialist
  • Global Submission Manager
  • Quality & Compliance Leader
  • Head of Regulatory Affairs

Because RA is a cross-border discipline, experienced professionals often work with multinational teams or relocate abroad.

Conclusion – Why This Matters

Every safe medicine you see on a shelf carries the invisible imprint of Regulatory Affairs. For students who value precision, ethics, and communication, it’s a career that offers meaning, mobility, and long-term growth.

Through industry-aligned training, hands-on projects, and holistic development, Cliniversity helps learners cross the bridge from campus to corporate life in RA. In doing so, we’re not only shaping careers but also strengthening the healthcare ecosystem that protects millions of patients.

Still got doubts and want to know more, call us on 7676838731

The post Regulatory Affairs: Building a Future-Proof Career in Pharma & Clinical Research appeared first on Cliniversity.

]]> https://www.cliniversity.com/regulatory-affairs-careers-india/feed/ 0 From Campus to Corporate: How Certification Programs Make You Job-Ready https://www.cliniversity.com/certification-in-pharma/ https://www.cliniversity.com/certification-in-pharma/#respond Thu, 04 Sep 2025 10:51:39 +0000 https://cliniversity.com/?p=4907 From Campus to Corporate: How Certification Programs Make You Job-Ready in Pharma & Clinical Research The pharmaceutical and life sciences industry is one of the most regulated, fast-moving, and people-driven sectors worldwide. Every new therapy, vaccine, or medical device you see on the market has travelled through years of research, clinical trials, regulatory reviews, and […]

The post From Campus to Corporate: How Certification Programs Make You Job-Ready appeared first on Cliniversity.

]]> From Campus to Corporate: How Certification Programs Make You Job-Ready in Pharma & Clinical Research

The pharmaceutical and life sciences industry is one of the most regulated, fast-moving, and people-driven sectors worldwide. Every new therapy, vaccine, or medical device you see on the market has travelled through years of research, clinical trials, regulatory reviews, and large multidisciplinary teams. For fresh graduates stepping out of college, this environment can seem both exciting and overwhelming.

Certification in pharma – acts as a bridge between academic learning and the demands of industry. At Cliniversity, our focus has always been to create clinical research training programs that are industry-aligned, practically relevant, and centered on holistic growth. This article explains how well-structured training can turn students into confident professionals ready to thrive in pharma and clinical research careers.

1. The Talent Gap in Pharma and Clinical Research

Despite India’s position as a global hub for clinical trials and pharmacovigilance operations, a persistent skills gap keeps employers from finding the right talent. Many science graduates complete their degrees with sound theoretical knowledge but limited exposure to real-world processes such as:

  • Clinical trial management training and documentation
  • Safety reporting and pharmacovigilance systems
  • Regulatory submission standards (ICH-GCP, FDA, EMA guidelines)
  • Communication with investigators, CROs, and sponsors

This gap slows down hiring and places pressure on existing teams. Industry-aligned certification programs plug this gap by offering training in real-time scenarios and standard operating procedures.

2. Beyond Textbooks: Practical Exposure and Case Studies

A typical university syllabus may only cover concepts. Our courses bring in live examples:

  • How an adverse event report is logged and escalated
  • Real-world data management practices in clinical trials
  • The structure of clinical study reports and medical writing assignments

This practical exposure helps learners translate academic knowledge into day-to-day work. Employers value candidates who already understand industry workflows, because it reduces onboarding time and error rates.

3. Building Communication as a Core Skill

Technical competence is only half the equation. In the pharma and clinical research world, professionals interact with ethics committees, investigators, regulatory agencies, sponsors, and even patients. Communication must be clear, ethical, and precise.

Our courses integrate communication skill development alongside technical training:

  • Drafting professional emails and reports
  • Presenting findings in team meetings
  • Handling cross-functional discussions and virtual collaborations

This focus on soft skills transforms graduates from being “knowledge holders” to “knowledge communicators,” which is a critical differentiator in career growth.

4. Holistic Development – The Cliniversity Approach

Job-readiness is not only about technical know-how. It is also about attitude, confidence, and adaptability. That’s why our programs include:

  • Interview preparation sessions with industry experts
  • Mock regulatory audits to simulate real pressure scenarios
  • Mentorship on ethics, professional etiquette, and time management
  • Continuous Learning Management System (LMS) access for revision and self-paced study

By combining these elements, we nurture professionals who can handle responsibilities independently, think critically, and adapt to evolving regulations and technologies.

5. Career Pathways After Our Programs

Graduates of our clinical research and pharmacovigilance courses have entered diverse roles such as:

  • Clinical Research Coordinator (CRC)
  • Clinical Data Manager (CDM)
  • Pharmacovigilance Associate / Drug Safety Associate
  • Regulatory Affairs Executive
  • Medical Writer or Medical Coder
  • Quality Assurance or Compliance Officer

These positions are stepping stones to leadership roles in Clinical Operations, Regulatory Strategy, and Safety Management. With India’s pharma and biotech sectors expanding globally, these skills are future-proof and in demand.

6. Why This Matters for Employers and Students

For students, a well-structured certification program shortens the learning curve and increases employability. For employers, it means access to a workforce that is already trained on global best practices. This alignment is essential for reducing project delays, ensuring patient safety, and meeting international compliance standards.

7. Our Commitment to Quality Training

At Cliniversity, we go beyond delivering lectures. Each module is designed with input from industry veterans who have hands-on experience in clinical trials, regulatory submissions, and pharmacovigilance. We also use real case scenarios to demonstrate ethical dilemmas and decision-making, ensuring our learners develop professional judgement, not just textbook answers.

Our training also emphasises lifelong learning. Even after completing a course, learners can revisit recorded sessions, update themselves and seek guidance from mentors. This continuous support system fosters confidence and long-term career growth.

Conclusion

Moving from campus to corporate life can be intimidating, especially in a highly regulated and rapidly evolving field like pharma and clinical research. However, with the right Certification program, graduates can build not just technical proficiency but also communication, professionalism, and confidence.

By focusing on practical skills, holistic development, and ethical practice, Cliniversity’s programs transform learners into industry-ready professionals. This benefits students, employers, and ultimately the patients who rely on safe and effective therapies.

For more queries reach out to us on

7676838731

The post From Campus to Corporate: How Certification Programs Make You Job-Ready appeared first on Cliniversity.

]]> https://www.cliniversity.com/certification-in-pharma/feed/ 0 Interview Questions and Answers for Pharma Freshers: How to Prepare and Stay Professional https://www.cliniversity.com/how-to-prepare-for-pharma-job-interviews-qa-tips/ https://www.cliniversity.com/how-to-prepare-for-pharma-job-interviews-qa-tips/#respond Fri, 29 Aug 2025 13:52:47 +0000 https://cliniversity.com/?p=4862 Starting a career in the pharmaceutical industry is an exciting step. Whether you are applying for a role in clinical research, pharmacovigilance, regulatory affairs, medical writing, or production, the interview is your chance to make a strong first impression. Many candidates feel anxious because they do not know what questions to expect or how to […]

The post Interview Questions and Answers for Pharma Freshers: How to Prepare and Stay Professional appeared first on Cliniversity.

]]> Starting a career in the pharmaceutical industry is an exciting step. Whether you are applying for a role in clinical research, pharmacovigilance, regulatory affairs, medical writing, or production, the interview is your chance to make a strong first impression. Many candidates feel anxious because they do not know what questions to expect or how to present themselves professionally.

This guide covers commonly asked interview questions, sample ways to answer them, and tips to stay confident, polished, and industry-ready.

1. Tell Me About Yourself

Why it’s asked: Interviewers want to see how well you can summarize your background and whether you are the right fit.

How to answer:

  • Start with your education.
  • Mention any project, internship, or training relevant to pharma.
  • End with why you’re interested in the role.

Example:
“I have recently completed my Master’s in Pharmacy with a focus on Clinical Research. During my internship, I gained exposure to trial documentation and regulatory guidelines. I am eager to begin my career in pharmacovigilance, where I can apply my knowledge and attention to detail.”

Tip: Keep it short, structured, and professional. Avoid personal details unless asked.

2. Why Do You Want to Work in the Pharmaceutical Industry?

Why it’s asked: To check your motivation and long-term interest.

How to answer:

  • Talk about your passion for science and healthcare.
  • Show awareness of industry growth and impact on patients.

Example:
“I want to be part of the pharmaceutical industry because it directly improves patient health and quality of life. With the rapid growth of clinical research and drug development in India, I see an opportunity to contribute to innovation and build a meaningful career.”

3. What Do You Know About Our Company?

Why it’s asked: To test preparation and interest in the employer.

How to answer:

  • Research the company beforehand (history, products, services, recent news).
  • Mention something specific about their work culture or reputation.

Example:
“I understand that your company is one of the leaders in generic drug manufacturing with a strong focus on quality and regulatory compliance. I also read that you have recently expanded your clinical trial operations, which excites me as I want to grow in that space.”

Tip: Never say “I don’t know.” Even a small piece of research shows effort.

4. How Do You Handle Stressful Situations?

Why it’s asked: Pharma jobs often involve deadlines and compliance pressure.

How to answer:

  • Share a practical approach like time management or teamwork.
  • Avoid saying “I never get stressed.”

Example:
“I prioritize tasks by urgency and break large assignments into smaller steps. In my project work, I used checklists and progress tracking, which helped me meet deadlines without compromising accuracy.”

5. Can You Explain the Difference Between Clinical Research and Pharmacovigilance?

Why it’s asked: To test your basic knowledge.

How to answer:

  • Keep it simple and clear.

Example:
“Clinical research is the process of studying new drugs or treatments through trials to check safety and effectiveness. Pharmacovigilance focuses on monitoring the safety of drugs after they are approved, by collecting and analyzing adverse event reports.”

Tip: Use short definitions, not textbook paragraphs.

6. Where Do You See Yourself in Five Years?

Why it’s asked: To check your career goals.

How to answer:

  • Show ambition but stay realistic.
  • Link your growth with company growth.

Example:
“In five years, I see myself in a responsible role where I can lead a small team, contribute to regulatory submissions, and mentor freshers. I believe this role will help me build a strong foundation for that path.”

7. Situational Question: If You Notice a Mistake in Trial Data, What Will You Do?

Why it’s asked: To see ethics and problem-solving skills.

How to answer:
“I would double-check the data first, document the issue, and immediately inform my senior or project manager. Accuracy and compliance are critical, so I would avoid making corrections on my own without proper approval.”

8. What Are Your Strengths and Weaknesses?

Why it’s asked: To test self-awareness.

How to answer:

  • For strengths → mention skills relevant to pharma.
  • For weakness → choose something genuine but manageable.

Example:
“My strength is being detail-oriented, which helps in documentation and quality checks. My weakness is public speaking, but I am actively improving it by volunteering for presentations.”

9. Do You Have Any Questions for Us?

Why it’s asked: To see curiosity and engagement.

Good Questions to Ask:

  • What kind of training programs are provided to freshers?
  • How does your company support career growth in pharmacovigilance?
  • What qualities do you value most in new hires?

Tip: Never say, “No questions.” Always prepare at least one.

Professionalism Tips for Pharma Interviews

  1. Dress Formally: A simple, well-ironed shirt and trousers or Indian formal wear is enough. Avoid flashy colors.
  2. Body Language Matters: Sit straight, make eye contact, and don’t fidget.
  3. Be Honest: Pharma companies value integrity more than “perfect answers.”
  4. Time Management: Reach the interview venue or log in online 10–15 minutes early.
  5. Carry Essentials: Updated resume, certificates, and ID proof.
  6. Follow-Up: Send a short thank-you email after the interview.

Final Thoughts

Pharma interviews are not about memorizing complex technical terms. Employers look for clarity, professionalism, and a genuine interest in the industry. By preparing for these common questions and practicing confident communication, you will stand out as a strong candidate.

Remember: Knowledge + Professionalism + Confidence = Success.

The post Interview Questions and Answers for Pharma Freshers: How to Prepare and Stay Professional appeared first on Cliniversity.

]]> https://www.cliniversity.com/how-to-prepare-for-pharma-job-interviews-qa-tips/feed/ 0 ROI of Clinical Research Courses: Worth the Investment? https://www.cliniversity.com/roi-of-clinical-research-courses-worth-the-investment/ https://www.cliniversity.com/roi-of-clinical-research-courses-worth-the-investment/#respond Tue, 24 Jun 2025 14:50:55 +0000 https://cliniversity.com/?p=4711 Clinical research has evolved as a lucrative and rewarding career option in the fast-paced healthcare and pharmaceutical industries. With growing global needs for trained clinical trials professionals, drug development experts, and regulatory affairs specialists, more people are opting for specialty training courses. However, the question lingers—is a clinical research course worth investing in?

The post ROI of Clinical Research Courses: Worth the Investment? appeared first on Cliniversity.

]]>

What You Get from a Course in Clinical Research

Professional training in clinical research gives you a solid grounding in:

Good Clinical Practice (GCP)

Ethics and Regulatory Guidelines

Data Management and Trial Monitoring

Pharmacovigilance and Safety Reporting

Cliniversity courses take it a step further by including industry-relevant modules, practical projects, and career guidance—getting you work-ready right from the first day.

Career Opportunities: Global Doors Ajar

Clinical research certification unlocks a vast array of job opportunities in the healthcare and pharmaceutical sectors. Graduates generally find themselves taking up roles such as

Clinical Research Associate (CRA)

Regulatory Affairs Executive

Trial Coordinator or Data Analyst

Pharmacovigilance Specialist

These are not only rewarding but also set you up for growth in a globally acclaimed, fast-paced industry.

ROI: A Lucrative Career

Although course fees are an initial commitment, there are prospects for professional development, job security, and future income in this field that often give a fair return on investment.  Clinical research professionals are in demand both in India and globally, and the career is also seen to provide competitive salaries, scope for rising up the corporate ladder, and the advantage of being part of top-notch healthcare organizations globally.

In general, professionals begin to see financial and career satisfaction benefits a few months after certification.

Why Cliniversity?

Cliniversity is unique in that it offers practical instruction, coaching, and assistance with job placement. Our goal is to produce professionals that are not just credentialed but also self-assured, empowered, and of the highest caliber.

The post ROI of Clinical Research Courses: Worth the Investment? appeared first on Cliniversity.

]]> https://www.cliniversity.com/roi-of-clinical-research-courses-worth-the-investment/feed/ 0 Global Job Opportunities in Clinical Research: Your Gateway to an International Career https://www.cliniversity.com/global-job-opportunities-in-clinical-research-your-gateway-to-an-international-career/ https://www.cliniversity.com/global-job-opportunities-in-clinical-research-your-gateway-to-an-international-career/#respond Tue, 24 Jun 2025 14:48:58 +0000 https://cliniversity.com/?p=4705 With the fast pace of the healthcare industry in the current scenario, clinical research has emerged as one of the most prestigious and rewarding careers globally. As there is a continuous need for secure and effective medical interventions, the need for skilled professionals in clinical trials, regulatory affairs, data management, and pharmacovigilance is greater than ever.

The post Global Job Opportunities in Clinical Research: Your Gateway to an International Career appeared first on Cliniversity.

]]>

Whether a life sciences graduate, doctor, or interested in public health, clinical research offers worldwide career prospects with competitive pay and career advancement.

Why Clinical Research is a Global Career

Clinical trials are no longer confined to a nation or a continent. Clinical trials are conducted by multinational pharmaceutical companies, contract research organizations (CROs), and regulatory authorities in Asia, Europe, North America, and others. This globalization opens doors for professionals to work abroad in the following roles:

Clinical Research Associate (CRA)

Clinical Data Manager

Regulatory Affairs Specialist

Clinical Project Manager

Pharmacovigilance Officer

These roles not only provide good advancement but also put experts on global teams, on the move, and up-to-date with the latest in medical advances.

Countries Leading to Hire Clinical Research Professionals

According to recent labor market statistics, the following countries have the greatest recruitment demands for clinical research professionals:

United States—largest hub for clinical trials and innovation in research.

Germany—Pharmaceutical R&D powerhouse of Europe.

India—A successful center for CROs and global studies.

Canada and Australia—offering highly qualified immigration avenues for research professionals.

Singapore and Japan—known for clinical excellence and hi-tech incorporation.

How Cliniversity Assists You in Going Global

We at Cliniversity educate future professionals with training on par with the industry, practical skills, and career guidance to assist you in preparing for global clinical research careers. We structure our courses to equip you with experiential learning and certification to attain international hiring standards.

Begin a global clinical research career!

Join Cliniversity today and enter into an international career!

Reach out to us for a free career consultation.

The post Global Job Opportunities in Clinical Research: Your Gateway to an International Career appeared first on Cliniversity.

]]> https://www.cliniversity.com/global-job-opportunities-in-clinical-research-your-gateway-to-an-international-career/feed/ 0 Why Now Is the Perfect Time to Start a Career in Clinical Research — And How You Can Too https://www.cliniversity.com/why-now-is-the-perfect-time-to-start-a-career-in-clinical-research-and-how-you-can-too/ https://www.cliniversity.com/why-now-is-the-perfect-time-to-start-a-career-in-clinical-research-and-how-you-can-too/#respond Mon, 09 Jun 2025 17:56:59 +0000 https://cliniversity.com/?p=4659 Have you ever felt that still, small voice speaking to you, "There is something more out there for you"?

The post Why Now Is the Perfect Time to Start a Career in Clinical Research — And How You Can Too appeared first on Cliniversity.

]]>

Perhaps you’re in a career that really isn’t that interesting to you anymore. Perhaps you’re interested in healthcare, science, or doing something that makes a difference—but weren’t sure how to get started. If you’re one of them, here’s the positive news: there’s never been a better time to enter a career in clinical research.

A Growing Field with Real Purpose

The world is rapidly evolving, and the healthcare sector is no different. Clinical research is the foundation for the creation of life-saving medications, vaccines, and treatment protocols. The post-pandemic era saw individuals appreciate the individuals behind these innovations: clinical researchers, coordinators, associates, and analysts who toil in the background.

International industry reports suggest that there is a tremendous upsurge in the demand for clinical research professionals not only in the United States but globally. Different organizations like hospitals, drug companies, and Contract Research Organizations (CROs) are looking for skilled professionals who are capable of linking scientific research with patient care.

You Don’t Need to Be a Doctor

The most beneficial part is that a medical degree is not necessarily required to pursue the field. In fact, many successful clinical research professionals come from non-medical backgrounds, such as nursing, pharmacy, and life sciences, as well as recent graduates looking for their first major chance.

It is most critical that you are inquisitive, committed, and courageous to start.

Start Your Academic Journey with Cliniversity

Cliniversity is of critical relevance in this respect. Whether you are a recent graduate or a professional looking to transition into a new area, Cliniversity offers practical, job-focused programs that are far from theoretical training, truly preparing you for actual jobs such as clinical research associate (CRA), clinical trial assistant (CTA), or clinical data manager.

Our mentors have gone where you’re going. They’ll accompany you, guide you, and prepare you for job-readiness—with self-assurance.

Final Remarks

This is not a matter of switching careers. This is a matter of transforming your life. Clinical research is a profession about purpose, development, and belonging to something bigger than yourself.

Then why hesitate? The ideal moment is when the past and future meet. That moment is now. Start your journey with Cliniversity today. Your future in clinical research is waiting.

The post Why Now Is the Perfect Time to Start a Career in Clinical Research — And How You Can Too appeared first on Cliniversity.

]]> https://www.cliniversity.com/why-now-is-the-perfect-time-to-start-a-career-in-clinical-research-and-how-you-can-too/feed/ 0 Top 5 clinical research interview questions & how to answer them with confidence https://www.cliniversity.com/top-5-clinical-research-interview-questions-how-to-answer-them-with-confidence/ https://www.cliniversity.com/top-5-clinical-research-interview-questions-how-to-answer-them-with-confidence/#respond Sat, 03 May 2025 05:20:49 +0000 https://www.cliniversity.com/?p=2869 Are you preparing for interviews in Clinical Research, Pharmacovigilance, or Regulatory Affairs?

In 2025, the life sciences sector is booming, with a growing demand for skilled and industry-ready professionals. Recruiters today seek more than just academic qualifications. They value clarity of thought, communication skills, and practical knowledge that aligns with industry standards.

Whether you’re a fresh graduate in life sciences or a healthcare professional transitioning into research, preparing well for interviews is the key to unlocking great career opportunities.

Here’s your comprehensive guide to succeeding in clinical research interviews, starting with the top 5 frequently asked questions and how to tackle them like a pro.

The post Top 5 clinical research interview questions & how to answer them with confidence appeared first on Cliniversity.

]]>

Top 5 Clinical Research Interview Questions & Sample Answers

1. What is GCP and why is it important?

Answer: Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials involving human participants. Governed by ICH-GCP guidelines, it ensures the safety, rights, and confidentiality of participants while maintaining the integrity and credibility of trial data.

Why interviewers ask this: To assess your knowledge of core clinical research principles and your commitment to ethical practices.

2. What is Pharmacovigilance and why is it important?

Answer: Pharmacovigilance (PV) involves the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems. It’s essential for maintaining drug safety, especially post-marketing.

Key components include:

  • Adverse Event (AE) reporting
  • Signal detection
  • Benefit-risk assessment
  • Risk minimization

Why interviewers ask this: To ensure you grasp the importance of patient safety and real-world drug monitoring.

3. How do you handle discrepancies in clinical data?

Answer: Handling data discrepancies involves a systematic approach:

  • Review source documents and Case Report Forms (CRFs)
  • Raise and manage data queries
  • Follow SOPs and reconciliation protocols
  • Collaborate with trial sites for clarifications
  • Ensure proper documentation

Why interviewers ask this: To evaluate your problem-solving skills, attention to detail, and ability to maintain data integrity.

4. Can you explain the drug approval process in India and the US?

Answer: India:

  • Begins with pre-clinical studies
  • Followed by Phase I to IV clinical trials
  • Submission of data to the DCGI for review and approval

US:

  • Similar clinical phases
  • Regulated by the FDA
  • Requires IND (Investigational New Drug), NDA (New Drug Application), or BLA (Biologics License Application), typically in CTD format

Why interviewers ask this: To check your awareness of national and international regulatory frameworks.

5. Why do you want to work in the pharmaceutical industry?

Answer: The pharmaceutical industry is innovative, fast-paced, and dedicated to improving global health. I am drawn to its dynamic nature, the opportunity to contribute to patient safety, and the potential for continuous learning and career growth.

Why interviewers ask this: To understand your personal motivation and career alignment with the industry.

Career Opportunities in 2025: The Landscape Ahead

The demand for professionals in Clinical Research and Pharmacovigilance is surging. Here’s why:

  • The global pharmacovigilance market is projected to surpass USD 12 billion by 2030, growing at a CAGR of 7%
  • India’s Clinical Trials sector is expected to grow at a rate of 12-15% annually

With increased focus on patient safety and regulatory compliance, trained professionals are more essential than ever.

Why Cliniversity is Your Ideal Training Partner

Cliniversity is committed to helping you become industry-ready. Our programs are curated by professionals and designed to help you learn, practice, and excel in real-world job roles.

Our Offerings Include:

  • Clinical Trial Management
  • Pharmacovigilance
  • Regulatory Affairs
  • Medical Writing
  • Medical Coding

What Makes Us Unique:

  • Flexible online class schedules
  • Live + recorded sessions for better learning
  • Lifetime access to our LMS
  • Hands-on software training (especially for PV)
  • Expert-led interview preparation
  • 100% placement assistance

Ready to Start Your Career in Life Sciences?

If you are passionate about making a difference in healthcare through research, Cliniversity is here to guide you every step of the way.

📞 Call us: 7676838731
🌐 Visit: www.cliniversity.com

Start your journey with Cliniversity today and build a career that makes a real impact.

To your success,
Team Cliniversity

The post Top 5 clinical research interview questions & how to answer them with confidence appeared first on Cliniversity.

]]> https://www.cliniversity.com/top-5-clinical-research-interview-questions-how-to-answer-them-with-confidence/feed/ 0 Your complete guide to becoming a certified medical coder https://www.cliniversity.com/your-complete-guide-to-becoming-a-certified-medical-coder-in-india/ https://www.cliniversity.com/your-complete-guide-to-becoming-a-certified-medical-coder-in-india/#respond Tue, 22 Apr 2025 04:59:27 +0000 https://www.cliniversity.com/?p=2857 In the ever-evolving healthcare industry, Medical Coding has emerged as a high-demand, high-responsibility profession. From hospitals and clinics to insurance companies and research organizations, certified medical coders are essential for the accurate documentation and billing of patient care.

If you're curious about how to become a certified medical coder and build a career in this vital domain, you're in the right place. This blog post offers a complete roadmap — from understanding what medical coding is, to getting certified, gaining experience, and ultimately landing a job in this competitive field.

The post Your complete guide to becoming a certified medical coder appeared first on Cliniversity.

]]>
What Is Medical Coding?

Medical coding is the process of converting healthcare diagnoses, treatments, and services into standardized alphanumeric codes. These codes are drawn from universal code sets such as:

  • ICD-10 (International Classification of Diseases)
  • CPT (Current Procedural Terminology)
  • HCPCS (Healthcare Common Procedure Coding System)

These standardized codes are used for medical billing, insurance claims, statistics, and patient records — making coders indispensable to the healthcare ecosystem.

Why Is Certification Important?

While theoretical knowledge is a starting point, certification proves that you’re industry-ready. A certified coder not only understands medical terminologies and coding standards but also stays compliant with healthcare regulations, which reduces the risk of claim rejections and billing errors.

Most recruiters, especially in reputed hospitals, insurance firms, and medical outsourcing companies, prefer or mandate certified candidates.

Step-by-Step Guide to Becoming a Certified Medical Coder

Step 1: Choose the Right Certification Path

Before you begin training, you need to decide which certification aligns with your career goal. There are multiple globally recognized certifications, but in India, two major ones stand out:

  • CPC (Certified Professional Coder) – Best for outpatient or physician coding roles
  • CCS (Certified Coding Specialist) – Ideal for hospital and inpatient coding positions

Tip from Cliniversity: Talk to our academic advisors to understand which certification suits your background and future aspirations. We’ll guide you based on your preferred work environment — whether it’s a clinic, corporate KPO, or hospital setting.

Step 2: Enroll in a Structured Training Program

Now that you’ve selected your certification path, the next step is enrolling in a quality medical coding training program.

At Cliniversity, we offer:

  • Advanced Medical Coding Certification (3 months) – ₹24,999

Each program is available online and includes:

  • In-depth Human anatomy and physiology training
  • ICD-10, CPT, and HCPCS code mastery
  • Real-time case study discussions
  • Doubt-clearing sessions with certified trainers

Our courses are designed for both freshers and working professionals, offering flexibility, mentorship, and exam readiness.

Step 3: Gain Hands-On Experience

Theoretical knowledge is critical — but practical exposure gives you an edge. While not mandatory for all exams, experience helps in understanding real-time clinical documentation and billing processes.

At Cliniversity, we bridge this gap through:

  • Internship support with healthcare providers
  • Live project simulations
  • Access to practice management software tools used in the industry

This real-world experience strengthens your resume and gives you the confidence to take on challenging roles after certification.

Step 4: Prepare Thoroughly for the Certification Exam

The medical coding certification exam isn’t just a formality — it tests your knowledge of medical concepts, coding guidelines, case-based applications, and speed of execution.

Here’s how Cliniversity helps you prepare:

  • Mock tests replicating the real exam pattern
  • Chapter-wise practice questions
  • Concept revision sessions
  • Access to certified faculty for personalized guidance

We also provide a study planner to help students prepare systematically and track their progress.

Step 5: Take the Exam & Get Certified

Once you’re ready, you can take your certification exam — usually conducted online. It consists of multiple-choice questions covering medical terminologies, anatomy, coding principles, and case scenarios.

  • The exam typically lasts 4–5 hours
  • A passing score is required for certification

If you don’t succeed on the first attempt, don’t worry — we’ll help you prepare for a successful retake. Upon passing, you earn credentials like CPC or CCS, which significantly boost your employability.

Step 6: Start Your Career in Medical Coding

With your certification in hand, it’s time to launch your career. Certified medical coders can work in:

  • Hospitals and outpatient centers
  • Health insurance companies
  • Clinical research organizations (CROs)
  • Medical billing & KPO companies
  • Government health departments

At Cliniversity, we support our graduates with:

  • Resume-building workshops
  • Interview preparation sessions
  • Placement assistance with top recruiters in the industry
Why Choose Cliniversity?

There are many institutions offering medical coding training, but Cliniversity stands apart for its student-first approach, industry-driven curriculum, and personalized mentoring.

Here’s what makes us your best choice:

  • Industry-Aligned Courses – We teach what employers look for
  • Flexible Learning Modes – Online with recorded session
  • Certified Faculty – Learn from practicing coders and trainers
  • Affordable Programs – With EMI and payment flexibility
  • Internship & Placement Support – We stay with you beyond the classroom
  • Vibrant Learning Community – Connect with fellow learners, alumni, and mentors 

We’re not just preparing you for a job — we’re building your future in healthcare.

 Final Thoughts

Becoming a certified medical coder is more than just earning a certificate — it’s about developing the skills to make a difference in the healthcare system. Whether you’re just starting out or making a career switch, the path is clear and achievable with the right guidance.

So, if you’re asking: “How do I become a certified medical coder in India?” — the answer begins here, at Cliniversity.

📞 Ready to take the first step? Call/WhatsApp: +917676838731
🌐 Visit: www.cliniversity.com

The post Your complete guide to becoming a certified medical coder appeared first on Cliniversity.

]]> https://www.cliniversity.com/your-complete-guide-to-becoming-a-certified-medical-coder-in-india/feed/ 0